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ABSTRACT 
Rainey, Felynncia Renee.  PhD.  The University of Memphis.  May/2012.  Towards 
Monitoring of the Anesthetic Drug Propofol: Design, Development, and Characterization 
of an Automated Flow Analytical System.  Major Professor:  Ernő Lindner, PhD. 
 
Propofol is an intravenous anesthetic drug commonly used for the maintenance of 
sedation for critically ill patients in the ICU.  Current standard dosing paradigms, which 
use weight, age, and sex to determine dosage amounts, are not universal to all patients.  
Consequently, some patients may be under-sedated, while others may be over-sedated.  
Patient under-sedation can affect patient comfort, proper patient-ventilator 
synchronization, and blood oxygenation.  Patient over-sedation can result in the 
development of Propofol Infusion Syndrome (PRIS).  PRIS can cause many 
physiological dysfunctions, even death, especially in children.  To address this issue an 
electrochemical propofol sensor and an automated flow analytical system (AFAS) have 
been designed in our lab.  The AFAS is aimed toward the feedback controlled monitoring 
of propofol using microfabricated planar electrochemical sensors.    
The AFAS is composed of a flow-through electrochemical cell, computer 
controlled actuator, multi-position valve, peristaltic pump, and potentiostat.  The system 
allows the user to implement complex analytical tasks, including flow injection analysis, 
continuous monitoring, and multipoint calibration with sample measurements.  
Measurements can be performed under varied experimental conditions, including a wide 
range of electrode configurations, sampling schemes, sample volumes, and sample 
concentrations.         
A membrane coated sensor for measurement of propofol has been developed. The 
AFAS was used to characterize the response of the membrane coated electrode in 
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repeated measurements, using ferrrocenemethanol as a model compound.  The influence 
of the thickness of the membrane on the measured electrochemical signal was also 
examined. 
Finally the AFAS was used to demonstrate the performance characteristics of a 
membrane coated sensor for the measurement of propofol.  The AFAS was also used to 
determine the precision and accuracy of propofol measurement in the physiologically 
relevant concentration range and the effect of interfering compounds on propofol 
measurement.   
 v 
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1 INTRODUCTION 
In the field of analytical chemistry there is a constant quest to improve the 
detection limit, the sensitivity and selectivity of the measurements, and to decrease the 
needed sample/reagent volumes.  There is also a drive to decrease analysis time without 
unduly sacrificing measurement accuracy.  Traditional chemical analysis is done using 
batch methods (i.e., pipetting, titrating, etc.), and is also known as beaker chemistry.  It 
has been the standard method of analysis for the past 200 years.  Batch methods are often 
time consuming and labor intensive.  Also, the errors associated with batch methods are 
highly user-dependent.   
With the advent of computer technology, the automation of chemical analysis 
became possible.  Computer controlled chemical analysis reduced analysis time, 
increased sample throughput, and improved the reproducibility of measurements.   
In the first stages of computer controlled systems, the steps of batch analysis were 
mechanized.  The samples were transported in disposable containers on a conveyor belt, 
while reagents were added and mixed with the sample by a mechanical stirrer.  Although 
these mechanized analyzers had distinct advantages, the machinery took up a large 
amount of space and were expensive to operate.
70
  
The next stage in the development of automated analytical systems appeared with 
the advent of flow analytical techniques.  Flow operations are the sequential movement of 
liquids through tubes.  With flow operations, microvolumes of sample can be metered 
and manipulated by pumping devices.  Flows can be mixed, stopped, restarted, reversed, 
split, recombined, and sampled.   Also, since the solution is contained within closed 
tubing the affects of evaporation can be avoided.  The tubing provides a repeatable 
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path(s) for solution movement and an environment for reproducible mixing of 
components.   
Flow analytical systems can be miniaturized and combined with microfabricated 
sensors to make lab-on-chip devices.
7, 14, 25, 46, 57, 70, 94
  Flow analytical systems have 
shown unique advantages when combined with electrochemical sensors.
17, 56, 70, 91
   
Automated flow analytical systems are used where a large number of samples are 
analyzed (e.g., the food/beverage industry, for environmental monitoring, and the 
pharmaceutical industry).
42, 58, 82, 84
  One of the main tasks of my doctoral work was the 
development of an Automated Flow Analytical System (AFAS) for monitoring the 
concentration of the anesthetic drug propofol during anesthesia. 
Propofol (2,6 – diisopropylphenol) is formulated in an oil-in-water emulsion that is 
1% propofol, 10% soybean oil, 1.2% purified egg lecithin, 2.25% glycerol and 0.005% 
EDTA.  The soybean oil and egg phospholipids are solubizing agents.  The EDTA 
inhibits bacterial growth.  Glycerol adjusts the osmotic pressure.   
The average induction time for propofol is between 40 and 78 seconds.
19, 85
  
Propofol is readily metabolized by the body, with less than 1% of the drug excreted 
unchanged.
85
  Propofol is metabolized mainly via the liver (70%) and the kidneys 
(30%).
49, 85
  The brain and lungs do not contribute to total body clearance of propofol.
85
  
The therapeutic concentration range of propofol in blood is between 0.25 and 16 
μg/mL.
60, 61, 74, 85
  This translates into a serum concentration between 1.4 and 89 μM.
85
  
Table 1-1 correlates propofol blood concentration to the Ramsay Sedation Scale.  
The Ramsay Sedation scale describes a patient‟s level of consciousness.  McKeage et al. 
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reported that a propofol blood concentration between 0.25 and 2 μg/mL correlate to a 
Ramsey sedation score of 2 – 5.
61




Table 1-1:  Correlation of propofol blood concentration with the level of consciousness.  
Concentrations with the „a‟ superscript are in the presence of fenantyl.   The table was 
reproduced and modified from McKeage et al.
61
  Data was added from Iwakiri et al., Liu 





Ramsay Sedation Scale Level of Sedation 
Awake Levels 












 4 Brisk response to stimulus 
2 
a
 5 Sluggish response to stimulus 
>2 
a




 6 Unconscious, no response to 
stimulus 
- - 15.2  9.6
a





Propofol‟s duration of effect (i.e., the length of time propofol has a 
pharmacological effect) is typically between 5 and 15 minutes.  It is dependent on the 
level and length of sedation.
61, 85
  Figure 1-1 shows the duration of effect for light 
sedation.  For propofol infusion times of 10 hours or less, recovery from anesthesia is 
within 5 to 15 minutes.  For infusion time longer than 10 hours, recovery is delayed 
because of the saturation of propofol in the fatty tissues.  Figure 1-1 shows that even after 
a 10 day infusion, propofol is eliminated fairly quickly, and the patient is awake within 







Figure 1-1:  Duration of propofol effect following the termination of infusion.  Figure 






It has been shown that propofol, like many other drugs, complexes with proteins 
in the blood.  Evidence has been shown that albumin, one of the most prevalent serum 
proteins, complexes propofol.  There is some debate about the number of propofol 
molecules that are complexed per albumin protein.  Early studies by Mazoit et al. suggest 
that there are more than 20 possible complexation points.
60
  However, more recent 
studies have demonstrated that there are only two regions on the albumin protein that 
bind propofol.
6, 54
  One of the regions was shown to have greater affinity for fatty acids.  
This region would most likely bind a fatty acid molecule instead of propofol.  To 
calculate the concentration of free propofol in serum, the stoichiometry of the propofol 
albumin complex and the binding constants must be known.  It has been estimated that at 
an EC50 (the concentration of the intravenous anesthetic in which 50% of patients will 
not respond to surgical stimuli)
55, 74
 concentration of 50 μM, there is only 7 μM of free 
propofol (i.e., non-complexed ) in the blood.
54, 60
  Lui et al. have reported a dissociation 
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constant for the albumin-propofol complex (Kd) of 65 μM.
54
  Kd indicates the 
concentration of the ligand (i.e., propofol) in which 50% of the proteins will have the 
ligand bound. 
Current Methods of Detection and Monitoring of Sedation 
Current methods used by clinicians to qualify the level of sedation are Observers 
Assessment of Alertness/Sedation (OAAS), Guedel‟s classification, and Bispectral index 
(BIS).
6, 20, 76
  OAAS uses the patient‟s response to stimuli to assess the depth of sedation.  
Guedel‟s classification uses physical signs, such as automatic breathing, eyelid reflex, 
and eyeball movements to assess the depth of sedation.  BIS is an algorithm that 
interprets a patient‟s electroencephalogram to determine the level of consciousness.    
Current offline methods of detection of propofol in blood are high performance 
liquid chromatography (HPLC) and gas-liquid partition chromatography (GLPC).
22, 27, 45, 
73
  Guitton et al. using gas chromatography were able to detect concentrations from 0.01 
to 10 μg/mL of propofol in whole blood.
27
  Vree et al. using HPLC reported a detection 
limit of 0.10 μg/mL.
45
  Although these offline methods have adequate detection limits, 
they are unsuitable for bedside measurements because: (i) the analysis time (sampling, 
sample treatment, measurement, etc.) is much greater than propofol‟s duration of effect; 
(ii) an extensive sample treatment is required before the measurement; and (iii) they 
require complex instrumentation that is often large/bulky.  
Other methods of propofol detection include monitoring propofol in human 
breath.
34, 36, 62, 78
  In an experiment by Hornuss et al., real time measurements of propofol 
in expired breath samples were correlated to propofol blood concentrations.
36
  However, 
there was a large patient-to-patient variation.   
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Although not approved for use in the United States, target-controlled infusion is a 
common practice around the world for intravenous anesthetics.  The systems use 
pharmacokinetic and pharmacodynamic models to predict propofol blood concentration.
1
  
These systems control the flow rate of an infusion pump and estimate the propofol 
concentration in blood based on the volume and concentration of propofol administered.  
In combination with a propofol sensor, these systems offer an attractive possibility for 
safe drug delivery based on measured concentrations of propofol in patients.    
1.1 Problem to be Addressed 
Propofol (Diprivan®) is one of the most wildly used anesthetic drugs for 
inductance and maintenance of sedation.  It is extensively used for critical care patients 
receiving mechanical ventilation.  In most cases, the goal of clinicians is to keep the 
patient slightly sleepy and pain free.
18
   However, current standard dosing paradigms, 
which use weight, age, and sex of the patient to determine dosage amounts, are not 
universal to all patients.  Consequently, some patients may be under-sedated while others 
may be over-sedated.  Patient under-sedation can affect patient comfort, proper patient-
ventilator synchronization, and blood oxygenation.
15
  Patient over-sedation can result in 
the development of propofol infusion syndrome (PRIS).   
PRIS is characterized by many physiological dysfunctions, such as metabolic 
acidosis, hemodynamic changes, acute renal failure, rhabdomyolysis, 
hypertriglyceridemia, hyperlipidemia, and cardiac dysfunction.
67
  In rare cases PRIS can 
even lead to patient death.  The triggering factors for PRIS include long term use of high 
doses of propofol, exogenous catecholamine or glucocorticosteroid administration, 
inadequate carbohydrate intake, and subclinical mitochondrial disease.
67, 97






Figure 1-2:  Diagram of the priming and triggering factors of PRIS.  Reproduced and 






While there are multiple triggering factors that contribute to the onset of PRIS, the 
main „priming factor‟ is critical illness, which is described by Vasile et al. as an “acute 
disease of the central nervous system: sepsis, burns, trauma, and pancreatitis”.
87
  Figure 
1-2 shows the proposed priming and trigger factors of PRIS and its physiological 
consequences.   
Children require larger doses of propofol for induction and maintenance of 
sedation.  Therefore, they are more predisposed to the development of PRIS.
16, 85
  
Although the exact number of PRIS cases are unknown, Crozier estimates that PRIS 
Priming Factor
Critical illness























affects every 1 in 270 patients.
16
  Because of these situations, a method for bedside 
monitoring of propofol is needed.  To our knowledge, there are no systems that monitor 
propofol blood concentration in patients under sedation or anesthesia. The goal of the 
current work was to demonstrate the feasibility of propofol monitoring using an 
electrochemical detector.  The final objective of the project is to provide a feedback-
controlled drug delivery device to maintain optimal propofol blood concentration in 
patients. 
1.2 Design of the Automated Flow Analytical System 
Our group works on the development of short turnaround time (STAT) sensing 
systems using microfabricated planar electrochemical sensors for point of care testing 
(POCT). The development requires the evaluation of the performance characteristics of a 
large number of electrodes and analysis of a large number of samples.  My task was to 
create a multipurpose Automated Flow-Analytical System (AFAS) to evaluate the 
performance characteristics of different sensors using various flow-analytical methods.  
The system would encompass sampling, sample transport/solution flow, and 
voltammetric detection.  Details of the AFAS can be found in Appendix A.  
The AFAS is composed of a flow-through electrochemical detector cell, a computer 
controlled valve positioner (actuator) in combination with a multi-position valve 
(sampling), a peristaltic pump (solution handling), and a potentiostat (measurement).  The 
development of the AFAS included: 
1. Selection of specific instruments to be used in the AFAS 
 
 9 
2. Selection of a control program platform (i.e., programming language), and design 
of a control program and graphical interface 
3. Testing the performance characteristic of the AFAS 
1.2.1 Selection of Instruments 
The criteria used for instrument selection are:   
1. The instrument can be electronically controlled via a computer interface (RS-232, 
USB, DAQ, etc.). 
2. The instrument has specifications that meet the requirements for an automated 
flow analytical system.  
3. If possible, utilize instruments already in the lab.   
Using these selection criteria, the following instruments were chosen as 
components of the AFAS.  The Modular Valve Positioner (MVP) (367898, Hamilton 
Company, Reno, NV) was selected because it could be used in combination with a 
variety of easily attachable valves.  In the AFAS the MVP is used in combination with 
the 6-port Distribution Valve (6-PD) (Model: 36781) or the 6-port Loop Valve (6-PL) 
(Model: 38760) (Hamilton Company, Reno, NV).  These valves allow the selection of up 
to 6 solutions (reagents or samples), and the implementation of a wide variety of 
sampling and analysis schemes.  We were also able to utilize two instruments, a 
peristaltic pump and potentiostat, which were already in the lab.  The Miniplus3 
Peristaltic Pump (F1155006, Gilson Incorporated, Middleton, WI) has the ability to start, 
stop, reverse, and control the rate of solution flow.  The CV-27 Cyclic Voltammagraph 
potentiostat (Model MF9030, Bioanalytical Systems Incorporated, West Lafayette, IN) 
can implement a variety of electrochemical techniques.  When combined with the PA-1 
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Pre-Amplifier (Model MF2200) amperometric measurements can be made in the 
nanoampere current range.    
Figure 1-3 shows a schematic view of the instrument communication/control and 
fluid pathways of the AFAS.  The computer contains the control program that 
communicates with each instrument in the system through various interfaces.  The 
potentiostat is connected to the computer via the NI-6221 DAQ card (National 
Instruments Corporation, Austin, TX) and an USB port.  The Modular Valve Positioner 
(MVP) is connected directly to the computer via the COM1 serial port.  The peristaltic 
pump is connected to the computer via the 506C Interface (Gilson Incorporated, 
Middleton, WI) and the COM2 serial port.  Analytes/reagents are selected by the MVP.  
The peristaltic pump is used to flow the selected analyte/reagent from the sampling point 
to the detector.  The selected analyte/reagent passes through the flow through 
electrochemical detector cell, which houses the electrode/sensor, and is deposited in a 






Figure 1-3:  Block diagram of the communication control and the fluid flow pathways in 




1.2.2 Design of the Control Program 
LabVIEW (National Instruments Corporation, Austin, TX) was chosen as the 
control program platform because it allows one to: (1) integrate and control multiple 
instruments, (2) design a sophisticated, user-friendly graphical interface, and (3) design a 
system that can evolve according to the needs of researchers.
9, 10, 81
  LabVIEW is widely 
used and has far-reaching applications in academia and industry.
12, 13, 21, 23, 37, 88
   The 
control program was designed using the following objectives: 
1. Allow the sequential activation of the system‟s instruments to perform flow 
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2. Automatically save experimental data, parameters, and procedures 
3. Save experimental data in a simple ASCII format for post hoc analysis 
4. Allow for the recall of saved experimental procedures 
5. Design a user-friendly graphical interface that effectively uses the available 
computer display space and provides the user with information on the status of 
experiments 
The Flow Analysis (FA) and Flow Injection Analysis (FIA) control programs, in 
combination with the AFAS (FA-AFAS/FIA-AFAS), allow for the implementation of 
complex flow analytical tasks.  Both programs allow the user to select and configure the 
valve attached to the MVP, and input an experiential procedure.  The FA program allows 
the user to control when (in which step in the experimental procedure) to apply an 
electrochemical technique.  The user can choose from two electrochemical techniques, 
cyclic voltammetry (CV) or chronoamperometry (CA).  In the FIA control program only 
CA can be used, and there is no user control of when to start and stop the CA experiment.  
A constant potential is applied throughout the entire experimental procedure.     
The FA program was designed for short-term application of an electrochemical 
technique (i.e., seconds to minutes).  The FIA program was designed for continuous long-
term (≤ 2 hours) chronoamperometric experiments.   
In cyclic voltammetry the potential of the working electrode is scanned according 
to a triangular potential waveform.  The current flowing through the working electrode is 
recorded as a function of the applied potential.  Figure 1-4 shows an example of a typical 












Figure 1-4:  Example cyclic voltammagrams for a reversible O + ne
-
 → R redox process 
for a macroelectrode and microelectrode.  Inset:  Applied potential-time excitation 





In cyclic voltammetry, the peak current of a macroelectrode and the steady-state 
current of the microelectrode are directly proportional to the concentration of the 
oxidized [O] or reduced [R] form of the analyte in the bulk of the solution.  The peak 









where n is the number of electrons, A is the electrochemically active surface area, C is the 
concentration, D is the diffusion coefficient, and v is the potential scan rate.  The steady-








where F is the Faraday constant and r is the radius of the disc.  
In chronoamperometric methods, the potential of the working electrode is stepped 
from a potential at which no faradic reaction occurs at the electrode surface, to a potential 
at which the surface concentration of the electroactive species drops to zero.
89
  The first 















t is time, and all other parameter are as stated previously.  Figure 1-5 displays a CA 
waveform and the i-t response transients for a macroelectrode and microelectrode.   The 
steady-state current for a disk microelectrode is given by Equation 3.  At long time 












E                      a.         b. 
Figure 1-5:  Example chronoamperometric current-time response transients for a 
reversible O + ne
-
 → R redox process with (a.) macroelectrode and (b) microelectrode.  




1.3 Detection Scheme 
The voltammetric determination of propofol (2,6 -diisopropylphenol) is 
challenging.  Similar to other phenolic compounds, detrimental electrode fouling occurs 
when measurements are performed in an aqueous environment.  Over time, the product of 
the electrochemical oxidation deposits onto the working electrode surface, causing a 
change in the electrochemical signal in repeated measurements within the same sample.  
This process is termed as electrode fouling.  Electrode fouling limits the applicability and 
the lifetime of a propofol sensor.  The electrode fouling can be drastically reduced if the 
electrochemical oxidation of propofol is performed in an organic environment.
44, 47
  
Consequently, our group is working on the development of an organic film-based sensor 
for the quantitative measurement of propofol.   
An organic film coated sensor has been shown to have several advantages 
compared to conventional working electrodes (i.e., without specific coatings).  With the 
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organic film coated sensor: (i) the electrode fouling is significantly reduced; (ii) the 
influence of common electrochemical interferences in biological samples, like ascorbic 








Figure 1-6:  Schematic view of propofol detection scheme.  A planar electrochemical cell 
is coated with a thin layer of the organic film.  When exposed to an aqueous propofol 
sample, propofol partitions into the organic film, and is oxidized on the surface of the 
working electrode (WE) when an adequate potential is applied.  CE – counter electrode. 
RE – reference electrode.  A and A
-





The organic film consists of high molecular weight polyvinyl chloride (PVC), 2-
nitrophenyl octyl ether (o-NPOE), tetradodecylammonium-tetrakis (pentaflourophenyl) 
borate (TDDA-TPFPhB), and an organic salt, either potassium tetrakis 
(pentaflourophenyl)borate (KTPFPhB) or sodium tetrakis[(3,5-bis(triflourmethyl)] 
phenylborate (NaTFPhB).  The PVC is the support structure of the organic film.  The o-
NPOE, a plasticizer, forms the organic environment in the film, and allows lipophilic 
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molecules (i.e., propofol) to preferentially partition into the film.  The TDDA-TPFPhB is 
an organic electrolyte that helps reduce the resistance of the film.  TDDA-TPFPhB is a 
highly lipophilic molecule that is not soluble in water.   
A film solution is made by dissolving the film components in tetrahydrofuran 
(THF).  The film is cast onto the surface of the planar electrochemical cell by spin 
coating.  To make it possible to coat the entire electrochemical cell with a thin layer of 
the plasticized-PVC film, a planar glass chip patterned with a microfabricated working 
(WE), counter (CE), and reference electrodes (RE) is used.  It is beneficial to coat the 
entire electrochemical cell, not just the working electrode, with the organic film.  In this 
arrangement no current is flowing across the solution/film interface, and the possibility of 
fouling on the surface of the film is reduced.  However, this arrangement requires that the 
electrodes are patterned close to each other to minimize the possible iR drop in the 
membrane.   
Figure 1-6 illustrates the detection scheme with the organic film coated 
electrochemical cell.  During a propofol measurement, the membrane modified electrode 
is immersed in an aqueous propofol sample.  Propofol partitions from the sample solution 
into the organic film.  When sufficient potential is applied to the working electrode, 
propofol is oxidized on the surface of the working electrode, and the counter electrode 
will reduce a component in the membrane, most likely oxygen (from the sample).  The 
oxidation current is directly proportional to the propofol concentration in the film, which 
is in equilibrium with the aqueous sample.  Consequently, the measured current is 




The objectives of this dissertation are: 
1. Show of the performance characteristic of the AFAS in combination with a flow-
through detector cell using planar, microfabricated electrochemical cells.  This 
task includes: (i) developing a thin-layer flow through cell to be used with 
microfabricated planar electrodes that is adequate for flow or stopped flow 
measurements; (ii)  metering and electrochemically analyzing microliter to 
milliliter quantities of analyte/solutions; (iii) monitoring the changes in 
concentration under varied flow conditions by implementing a variety of flow 
analytical techniques; and (iv) designing experimental procedures for continuous 
monitoring experiments.  The characterization of the AFAS is discussed in 
Chapter 2. 
2. Evaluate characteristics of a membrane coated voltammetric sensor when it is 
incorporated into the automated flow analytical system (AFAS).  This task 
includes: (i) the characterization of a thin, PVC membrane coated electrochemical 
cell using ferrocenemethanol as a model compound; (ii) demonstrating the 
influence of the membrane thickness on the electrochemical signal; and (iii) 
comparing the performance characteristics of voltammetric analysis in the AFAS 
using microfabricated sensors with or without membrane coating. The response of 
the membrane coated sensor to ferrocenemethanol is discussed in Chapter 3. 
3. Adapt the AFAS for propofol measurements and demonstrate performance 
characteristics of a membrane coated propofol sensor when it is incorporated into 
the AFAS.  This task includes: (i) the determination of the precision and accuracy 
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of propofol measurement in the physiologically relevant concentration range; and 
(ii) determination of the effect of interfering compounds, such as ascorbic acid, 
and para-amidophenol, on the propofol measurement.  The response of the 
membrane coated sensor to propofol is discussed in Chapter 4.  
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2 AUTOMATED FLOW ANALYTICAL SYSTEM CHARACTERIZATION 
2.1 Valves 
Selection and sampling of solutions is performed using the 6-Port Distribution (6-
PD) and the 6-Port Loop (6-LP) valves.  A schematic of the valves depicting their fluidic 






Figure 2-1:  Schematic representation of the flow pattern of the (a) 6-Port Distribution 
Valve and (b) the 6-Port Loop valve which are used in combination with the MVP. Taken 






Each valve has an internal cylinder that can be rotated in the clockwise or 
counterclockwise direction.  The rotation of the cylinder in the 6-PD valve allows the 
selection of a solution from 6 different input ports (Figure 2-1a).  The rotation of the 
cylinder in the 6-PL valve allows the selection between Load and Inject flow 
configurations (Figure 2-1b).  In the Load position an attached sample loop is filled with 
a sample solution, while a carrier solution bypasses the loop and flows directly to the 



















sample is transported by the carrier solution to the detector.  The technique in which a 
bolus liquid sample is injected into a flowing stream of carrier solution and is carried by 
the flow to the detector, is called Flow Injection Analysis (FIA).
80
   
FIA was developed for the rapid analysis of small sample volumes.  The use of 
small sample volumes is beneficial if the sample is expensive, precious, limited, or toxic 
to the environment.  In FIA as the sample is transported from the injection point to the 
detector it becomes dispersed.  The dispersion in a flow analysis system is highly 
reproducible, and can be controlled through the experimental conditions.  Consequently, 
FIA can be used for the controlled dilution and analysis of highly concentrated samples.  
Figure 2-2 displays the concentration profile of an injected sample plug upon its injection 
(C
0
), and the dispersed sample plug at a certain distance from the injection point.  The 
sample is dispersed both radially and longitudinally.  The dispersion depends on the 
experimental conditions and the physical parameters of the flow path.  The dispersion of 










where D is the dispersion factor, C
0
 is the injected sample concentration, and C
max
 is the 






Figure 2-2:  The initially injected sample zone (top left) disperses as it moves through the 
flow path (top right). The concentration profile at the initial injection, with a 
concentration equal to the sample concentration C
0
 (bottom left), changes to a dispersed 
concentration gradient with the maximum concentration, C
max







With the 6-PL valve, to change the injected sample volume, the sample loop has 
to be replaced with a different sample loop.  The 6-PL valve can only sample a single 
analyte.   
The 6-PD valve can be transformed into an injector valve by using time-based 
injections.  In this configuration one of the six ports is designated for the carrier solution, 
and another is designated for the sample.  The other available ports may be used for 
calibration standards.  To perform a flow injection the valve is rotated from the carrier 
port to the sample port, and the sample is flowed for a specific amount of time.  The flow 
rate of the solution determined the amount of sample injected.  The valve is then rotated 
back to the carrier solution, which washes the sample to the detector.   
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2.2 AFAS Operational Flow Schemes 
2.2.1 Flow Injection Analysis Program controlled AFAS (FIA-AFAS) 
The FIA-AFAS is used for flow injection analysis.  In a FIA-AFAS experiment a 
potential is applied to the working electrode throughout the experiment, and the current 
flowing between the working and counter electrodes is continuously measured.  The 
current is directly proportional to the concentration of the solution in contact with the 
working electrode.  Consequently, the i-t transient has the same shape as the 
concentration profile shown in Figure 2-2 (bottom right). 
 Figure 2-3 shows an AFAS operational scheme for a FIA experiment utilizing the  
6-PL valve.  The flow scheme shown in Figure 2-3 will be referred to as Scheme 1.  As 
the sample loop is filled from the sample receptacle (i.e., beaker, patient, vial, etc.) by 
Pump 2, a carrier solution is pumped by Pump 1 through the flow-through detector cell 
and then to a waste receptacle.  The flow-through detector cell contains a planar 
microfabricated chip, which is connected to the potentiostat.  When only the carrier 
solution is within the flow-through detector cell, a background current (a capacitive 
current unrelated to a faradic process) is measured. Once the sample loop is filled, the 
valve is rotated to its inject position.  The carrier solution washes the sample plug into the 
flow-through detector cell.  As the electroactive sample comes in contact with the 
electrode, the electrochemical reaction at the working electrode generates a current 
proportional to the concentration.  As the plug exits the flow-through detector cell the 
current decreases back to the background current.  To minimize the amount of necessary 
sample and waste, the sample can be recycled back to the sample receptacle.  
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If the rate of concentration change in the sample receptacle is slow, compared to 
the frequency of injections and measurements, FIA is adequate to „continuously 
monitor‟ changes in the sample concentration.  This is analogous to the digital sampling 
and reconstruction of an analog signal. 
 
 
.   
 
Figure 2-3:  Scheme 1.  Flow injection analysis flow operational scheme utilizing the 6-
PL valve.  
 
   
 
The FIA-AFAS can also be used in combination with the 6-PD valve as shown in 
Figure 2-4.  This flow operational schematic is referred to as Scheme 2.  As stated 
previously, the 6-PD valve can be used as a time-based injector valve with single ports 
designated for the sample and carrier solutions, and the other ports available for 
calibrating standards.  Figure 2-5 shows an example i-t transient in which 4 standard 
solutions, of increasing concentration, were injected in the carrier stream followed by the 
injection of the sample.  The use of calibrating standards allows the construction of a 












calibration curve can be used for the quantification of unknown sample concentrations 






Figure 2-4: Scheme 2.  Flow injection analysis flow operational scheme utilizing the 6-
















Figure 2-5:  Example current-time transient of a FIA scheme utilizing the 6-PD valve for 




2.2.2 Flow Analytical Program controlled AFAS (FA-AFAS) 
The FA-AFAS is a general purpose system, which can implement different 
electrochemical methods with a variety of fluidic and sampling schemes. The sample 
solution may be stopped in the flow-through cell, or continuously pumped during the 
measurement.  The stopped flow option is beneficial for processes/reactions with slow 
kinetics and also minimizes waste.  The continuous flow option increases the flux and 
therefore offers a higher sensitivity.   
Both of the flow operational schemes shown in Figures 2-3 and 2-4 can be 
implemented in combination with the FA-AFAS.  With injected samples, the sample 
must be moved into the flow-through detector cell and the solution flux stopped before a 






The measured current depends on the concentration of the sample within the flow-
through detector cell.  If the dispersed sample volume is larger than the volume of the 
flow-through detector cell, the measured current reflects a section of the concentration 
profile of the dispersed sample that is within the flow-through detector cell.  Figure 2-6 
shows a concentration profile for an injected sample plug and displays CVs at 3 specific 
time instances corresponding to regions of the dispersed sample plug.  The transient 
concentration, related to the progression of the sample plug through the flow-through 
detector cell, can be constructed from consecutive measurements reflecting the 
consecutive concentration regions.  Unlike the FIA-AFAS, the FA-AFAS does not record 
the entire transient related to the progression of the sample plug through the flow-through 
detector cell, but performs a measurement at a certain region of the dispersed plug.  For 









Figure 2-6:  Concentration profile of an injected sample plug in the flow channel at a 
certain distance from the injection point, e.g., in the electrochemical flow-through 
detector cell.  Inserts:  CV measurements performed with the FA-AFAS at different time 




Figure 2-7 shows a flow operational scheme that can be implemented with the 
FA-AFAS (Scheme 3) to characterize electrodes.  The 6-PD sampling valve is connected 
to standard solutions of varying concentrations.  The valve selects a standard, and the 
pump moves the solution into the flow-through detector cell.  Electrochemical 
measurements can be performed under stopped-flow or flowing conditions.  The current 







































































































































Schemes 1 through 3 are just examples of flow schemes that may be performed 
with the AFAS.  Other schemes and procedures may be developed according to the user‟s 
needs. 
 
2.3 AFAS Operating Parameters 
The FA program allows programmed measurement.  In experiments with a 
multitude of washing, conditioning, and reaction steps, the user can program when to 
perform the electrochemical measurement.  This feature is beneficial when the 

















Figure 2-8 displays the experimental protocol task-pane for the FA program.   
This task-pane allows the user to input an experimental protocol using one line/row for 
each step in an experimental procedure.  Each step in the experimental protocol is 
composed of five elements (a) Valve Position (b) Pump RPM, (c) Pump Time, (d) Wait 
Time and (e) Measure, which are described as follows:   
a. Valve Position – This control allows the user to select a specific valve position for 
a specific protocol step.   
b. RPM – The RPM (rotations per minute) control allows the user to select the 
rotation speed of the peristaltic pump for a specific protocol step.  
c. Pump Time – The pump time control specifies how long the pump will be active 
for a specific protocol step.   
Experimental 
procedure 








d. Wait Time – The wait time control stops the pump, and the system waits the 
specified time for a specific protocol step. 
e. Measure – The measure control specifies if a measurement will be taken during a 
specific step of the experimental protocol.  This is a Boolean control.  It is either 
ON or OFF.  A green, oval LED is used for this control.  When the LED is bright-
green measurement is ON at that step.  When the LED is opaque-green 
measurement is OFF for that step.  
The experimental procedure task-pane in Figure 2-8 displays a three step time-
injection procedure similar to Scheme 2.  Position 1 of the valve is connected to the 
carrier solution, and Position 2 is connected to the analyte solution.  The FA program 
interprets the experimental procedure as follows: 
1. Load the 1st step in the experimental procedure 
a. Send electronic command to the MVP and rotate the valve to Position 1 to select 
the carrier solution. 
b. Send electronic commands to the peristaltic pump to (1) set pump tumbler 
rotation speed to 5 RPM, and (2) activate tumbler rotation which initiates flow of 
carrier solution.   
c. The system then counts down the pump time from 30 seconds to zero (i.e., flows 
the carrier solution for 30 seconds).   
d. The wait time is 0, do nothing.  Continue flowing carrier solution. 
e. Measure is not active, do nothing. 
2. Load the 2nd step in the experimental procedure.   
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a. Send electronic command to the MVP, and rotate the valve to Position 2 to select 
the analyte solution. 
b. Send electronic commands to the peristaltic pump to (1) set pump tumbler 
rotation speed to 5 RPM, and (2) activate tumbler rotation which initiates flow of 
analyte solution. 
c. The system then counts down the Pump Time from 60 seconds to zero (i.e., flows 
analyte solution for 60 seconds). 
d. Send an electronic command to stop pump.  The system counts down the wait 
time from 3 to zero (i.e., stops flow of analyte solution and wait for 3 seconds).  
e. The Measure Boolean is active.  The system applies the selected electrochemical 
technique and reads the response from the electrode/sensor.  The measured 
current is directly proportional to the concentration of the sample located 
within the flow-through detector cell (see Figure 2-6).   
3. Load the 3rd step in the experimental procedure.   
a. Send electronic command to the MVP, and rotate the valve to Position 1 to select 
carrier solution.   
b. Send electronic commands to the peristaltic pump to (1) set pump tumbler 
rotation speed to 1 RPM, and (2) activate tumbler rotation which initiates flow of 
carrier solution. 
c. The system then counts down the Pump Time from 200 seconds to zero (i.e., 
flows the carrier solution for 200 seconds and washes the analyte solution 
from the flow-through detector cell). 
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d. Send an electronic command to stop pump.  The system counts down the wait 
time from 3 to zero (i.e., stop flow of carrier solution and wait for 3 seconds).  
e. The Measure Boolean is active.  The system applies the selected electrochemical 
technique and reads the response from the electrode/sensor.  A non-faradic 
current will be measured because no electroactive species are within the 
flow-through detector cell.   
For the protocol in Figure 2-8, two measurements were performed.   
Figure 2-9 displays the experimental protocol task-pane for the FIA program.  
Essentially the same experimental procedure is shown, except there is no step-by-step 
measurement control.  A potential is applied continuously to the working electrode 
throughout the experimental procedure.  The FIA program interprets the experimental 
procedure the same as above, only step „e‟ is eliminated.  For the protocol shown in 
Figure 2-9 only one measurement is performed, and the measured current is directly 
proportional to the concentration of the sample plug as it flows through the flow-through 





Figure 2-9:  Experimental procedure task-pane for the FIA control program. 
 
 
Both the FA and FIA programs have the ability to automatically repeat an 
experimental procedure an user-specified number of times via a cycle control.  This 
allows for the easy construction of long-term experiments. 
2.4 Experimental 
2.4.1 Microfabricated Planar Electrode Chip 
Planar electrochemical cells were fabricated by Aegis Technologies Group, Inc. 
(Huntsville, AL).  The electrochemical cells were patterned on 11.67x11.16 mm glass 
chips with a gold microdisk electrode array (MEA), and two gold macroelectrode with 
surface areas of 0.0125 and 0.158 cm
2
.  The larger macroelectrode was utilized as a 
counter electrode and the smaller as a reference electrode.  The MEA was utilized as the 
working electrode.  The MEA is composed of individual disk electrodes which are 
interconnected and arranged in a hexagonal fashion.  Two MEA chip configurations were 
Experimental 
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used: (i) a 2 μm MEA with individual disk diameters of 2 μm and a 20 μm center-to-
center disk separation, and (ii) a 10 μm MEA with individual disk diameters of 10 μm 
and a 150 μm center-to center disk separation.  Figure 2-10 shows a picture of a 2 μm 
MEA chip.  Both chip configurations have a MEA diameter of 3 mm and an 
electrochemical cell diameter of 6 mm.    
The limiting current for a microdisk electrode array with recessed individual 

















where N is the number of individual microdisk electrodes in the array, n is the number of 
electrons, F is the Faraday constant, D is the diffusion coefficient, C is the concentration, 
r is the radius of an individual microdisk, and l is the depth of the recess.  Unfortunately, 
Equation 5 could not be used to describe the limiting current of the 2 μm MEA.  The 
actual 2 μm MEA geometry did not meet MEA design parameters.
28, 29
  Consequently, 






Figure 2-10:  Left:  Picture of a 2 μm MEA chip with microelectrode array, counter, and 
reference electrodes.  The diameter of the microelectrode array is 3 mm.  The diameter of 
the electrode cell is 6 mm.  A picture of the boxed area is shown on the right.  Right:  
Magnified view (200x) of the MEA, each dot is an individual microdisk electrodes with 
diameters of 2 μm. 
 
 
 In some experiments planar interdigitated band array (IDA) electrodes were used 
as working electrodes.  The IDA chips were fabricated by Aegis Technologies Group Inc.  
An IDA is made up of closely-spaced parallel microbands in which every other band is 
interconnected.
86
  The interconnection of these bands forms the two „fingers‟ of the IDA.  
The smaller the band gap between the fingers of the IDA, the higher the collection 
efficiency and amplification.
65
  The 2 μm IDA has a band-gap and band separation width 
of 2 μm. The chip also contains two gold macroelectrodes with surface areas of  0.013 
and 0.66 cm
2
.  The smaller of these macroelectrode served as a reference electrode, while 
the larger served as a counter electrode.  In our experiments, the two „fingers‟ of the IDA 
were interconnected, and the IDA was used as a macroelectrode.         
2.4.2 Thin-Layer Flow-Through Detector Cells 
Two thin-layer flow-through detector cells were designed, fabricated, and tested 








two Teflon blocks (Figure 2-11).  The top block contains the inlet and outlet ports, and a 
silver rod that forms a silver coplanar disk.  The silver disk was used as a reference 
electrode.   The bottom block is comprised of two gold rods which form two disk-shaped 
coplanar macroelectrodes with surface areas of approximately 0.034 cm
2
.  One of the 
gold electrodes was used as the working electrode, and the other electrode was used as 
the counter electrode.  A 0.002 inch thick Teflon gasket was used to create a chamber 
volume of approximately 3.5 μL.  The top and bottom blocks were pressed together using 
four screws located at the corners of the Teflon blocks.  The inlet and outlet ports are 
connected to the MVP and pump, respectively.     




Figure 2-11: Teflon block thin-layer flow through cell.  Left:  Planar view of the top and 
bottom Teflon blocks.  The top block contains the inlet/outlet ports and a Ag reference 
electrode.  The bottom block contains two Au electrodes which are used as working and 
counter electrode.  A 0.002 inch thick Teflon gasket is placed between the top and bottom 
blocks to form a 3.5 μL volume chamber.  Right: Cross-sectional view across the center 
of the thin-layer flow through cell composed of two Teflon blocks.  Solution enters into 
the inlet port, flows through the flow-through detector cell and exits through the outlet 


























The second flow through cell was designed to be used in combination with planar 
microfabricated electrode chips.  Figure 2-12 displays the schematics of the flow through 
cell.  All dimensions are in millimeters.  The top and middle blocks were composed of 
polycarbonate.  Polycarbonate was chosen because it is transparent, scratch resistant, has 
a low non-specific absorption,
26
 and is easily machined.  The clamp and the bottom block 





Figure 2-12:  Clamp-style thin layer flow through cell.  Flow through cell is designed to 
be used with microfabricated planar chips.  The cell is composed of a clamp and 3 inner 
blocks that move on sliding rods and casters.  The top block contains the fluid inlet and 




The top block contains the inlet and outlet ports.  A close-up view is shown in 









Oak Harbor, WA) was screwed into the ferrule connector port, creating a watertight seal 
and connecting tubing to the inlet and outlet ports.  The ferrule is designed to fit tubing 
with an outer diameter of 1/16 of an inch.  The inlet/outlet ports have a diameter of 0.76 
mm, and were designed to match tubing with an inner diameter of 0.030 inches.   
The middle block was used as a cushioning/positioning block.   Figure 2-13 
shows a cross-sectional view of the top and middle blocks, with the planar 
microfabricated electrode chip and the gasket pressed between the top and middle blocks.  
The length of the space measured between the outer edge of the inlet port and the outer 
edge of the outlet port was 6 mm, and this length was designed to fit over the entire MEA 
3-electrode cell.   
The dimensions of the gasket are shown in Figure 2-14.  The gasket was designed 
to be placed on top of the planar microfabricated chip with the 6.24 mm hole, located in 
the center on the gasket, forming a chamber over the working, counter and reference 
electrodes.  The gasket had a length of 12.61 mm and a width of 11.67 mm.  The reaction 
chamber was made by punching a 6.24 mm hole through the silicon rubber.  The chamber 
hole was centered horizontally, and positioned vertically 2.33 mm from the top and 3.15 
mm from the bottom.  The clamp flow-though cell was used in combination with a 0.5 











Figure 2-13:  Magnified view of the flow-through detector cell displaying a cross-
sectional view of a planar electrode chip and gasket pressed between the top and middle 
blocks.  Solution enters and exits the chamber formed by the gasket through the inlet and 





Figure 2-14:  Clamp-style flow-through detector cell gasket for use with MEA chips. 
 






    
2.4.3 Microelectrode Array Cell Preparation 
All three electrodes in the planar electrochemical cell were cleaned 
electrochemically using CV before use.  During electrochemical cleaning, the electrode 
to be cleaned was used as the working electrode.  An external silver wire and a platinum 
coil electrode were used as reference and counter electrodes, respectively.  The electrodes 
were placed in a 0.2 M sulfuric acid solution, and the potential of the working electrode 
was cycled between 0 and 1.2V at a scan rate of 300mV/s.  Typically 10 scans were used.  
Figure 2-15 displays CVs of a clean 2 μm MEA.  The peaks displayed in the CV are from 
the oxidation and reduction of gold.
31
  If the electrodes cannot be fully cleaned by 
electrochemical means (i.e., extra peaks observed), the electrodes were cleaned in a RF 
Plasma Cleaner/Sterilizer (Harrick Scientific Corp., Ossining, NY).  A high RF (10-12 
MHz) air plasma was applied to the chip at 300 mTorr for 3 minutes.  The electrodes 
were then rinsed with methanol and DI water.  The small gold macroelectrodes located 
on the MEA and IDA chips were modified to create Ag/AgCl reference electrode.  The 
gold macroelectrodes were electroplated with Ag/AgCl using Silver Cyless ® Conc and 
0.1 M NaCl solutions using established protocols.
8, 30, 38


























Figure 2-15:  CVs of a clean 2 μm MEA in 0.2 M H2SO4 using a silver wire as reference 




2.4.4 Cleaning of the Gold Macroelectrodes in the Teflon Block Flow-Through 
Detector Cell 
First, the electrodes were polished with 600 and 1200 grit abrasive paper for 5 
minutes each.  Next, the electrodes were polished with 1.0, 0.3 and 0.05 micron alumina 
paste for 5 minutes each.  Finally, the electrodes were rinsed with methanol and DI water.  
2.4.5 Chemicals and Reagents 
Potassium hexacyanoferrate (III) trihydrate, 99% (K3Fe(CN)6 x 3H2O) and  
ferrocenemethanol, 97% (FcMeOH) were purchased from Sigma-Aldrich (St. Louis, 
MO).    Tetradodecylammonium chloride (TDDACl) was purchased from Fluka 
Analytical (St. Louis, MO).  Potassium tetrakis(pentaflouropheyl) borate (KTPFPhB) was 
purchased from Boulder Scientific (Longmont, CO). Sodium tetrakis[(3,5-
bis(triflouromethyl)]phenylborate (NaTFPhB) was purchased from Dojindo Molecular 
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Technologies Inc. (Rockville, Maryland).  Tetradodecyammonium-
tetrakis(pentaflourophenyl) borate (TDDA-TPFPhB) was produced by metathesis.
44
  
Dichloromethane (≥99.5%) was purchased from Sigma-Aldrich (St. Louis, MO).  2-
nitrophenyl ocytl ether (o-NPOE) and high molecular weight polyvinyl chloride were 
purchased from Fluka Analytical (St, Louis, MO).  Silica Gel (GF-TLC) was purchased 
from Selectro Scientific (Suwanee, GA).  Fiberglass 9 Micron was purchased from 
Corning Incorporated (Corning, NY). Tetrahydrofuran (Certified) was purchased from 
Fisher Scientific (Pittsburgh, PA).  2,6-diisopropylphenol (97%), 4-Acetomido-phenol, 
and L-ascorbic acid was purchased from Sigma-Aldrich (St. Louis, MO).  A stock 
solution of 10 mM DIPP + 0.1M NaOH was prepared and refrigerated until ready for use.  
A 0.1 M PBS pH 7.2 solution (0.1 M sodium phosphate, dibasic + 0.1 M sodium 
phosphate, monobasic +100 mM potassium chloride) was used as a background/carrier 
solution.  This will be known as Buffer 1.  Buffer 2 contains the same formulation as 
Buffer 1, only the KCl was eliminated.  The composition of the background electrolyte 
for voltammetric measurements and the carrier solution used in flow measurements was 
the same.  Solutions were sonicated for 5-10 minutes prior to use. All aqueous solutions 
were prepared with deionzed (DI) water with a resistivity of 18 MΩ∙cm
-1
 obtained from 
the Milli-Q Gradient A10 System (Millipore, Billerica, MA).  Silver Cyless ® Con (6 TR 
oz AG/gallon) was purchased from Technic Inc (Cranston, RI), and used to electroplate 
silver onto the gold electrode for the preparation of the reference electrode.  All other 
chemicals were reagent grade and purchased from commercial sources. 
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2.4.6 Preparation of Organic Electrolyte   
Tetradodecyammonium-tetrakis(pentaflourophenyl) borate (TDDA-TPFPhB) was 
produced by metathesis.
44
  A 1:1 molar ratio of KTPFPhB and TDDACl was dissolved in 
dichloromethane (DCM).  An equal amount of DI water was added to the solution.  The 
solution was gently agitated and allowed to stand for 1 hour.  After an hour the aqueous 
and organic portions of the mixture were visibly separated.  The organic portion of the 
mixture was decanted and the aqueous portion discarded.  This separation was repeated 
three times.  The DCM was then evaporated under vacuum and the mass of the TDDA-
TPFFPhB compound measured.  The produced TDDA-TPFPhB was a viscous liquid with 
a slightly yellow color.  A yield of 96-98% was achieved.  For easier handling, the 
TDDA-TPFTPhB was dissolved in a small amount of DCM.   
2.4.7 Organic Film Solution 
The propofol measurements were performed with an organic film coated sensor.  
The organic film was composed of 22% PVC, 44% o-NPOE, 22% TDDA-TPFPhB and 
12% of either KTPFPhB or NaTFPhB.  The o-NPOE was cleaned by forcing it through a 
column of silica gel.   Compacted fiberglass was used as a stopper to retain the silica gel 
within the column. The film solution was created by dissolving the membrane 
components in THF.   
2.4.8 Film Deposition Protocol   
The organic film was deposited onto the electrode chip surface by spin coating 
using a membrane centrifuge.  The MEA chips were held stable on the vacuum chuck of 
the rotator column, located in the center of the membrane centrifuge.  Approximately 100  
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μL of the organic film solution was injected onto the chip surface, which was rotated at a 
rate of 1000 RPM.  The thickness of the deposited film depends on the rotation rate and 
the concentration of the film solution.  Two film thicknesses of approximately 1.7 μm 
(59.5 mg PVC/119 mg o-NPOE/59.5 mg TDDA-TPFPhB/29.8 mg KTPFPhB /2.6 mL 
THF) and 1.0 μm (32.0 mg PVC/64 mg o-NPOE/32.0 mg TDDA-TPFPhB/16.0 mg 
KTPFPhB/1.9 mL THF) were deposited onto surface of electrodes.  The thickness of the 
films were determined with the Alpha Step 500 Surface Profiler (Tencor Corporation, 
Milapitas, CA) using a stylus force of 1.4 mg and a scan speed of 2 μm/s.  The film was 
carefully sliced using a razor blade, and half of the film was removed from the glass chip.  
The thickness of the film was determined by moving the stylus in a line from an area of 
the chip with the film to an area in which the film had been removed.  The thickness of 
the film was determined by the height difference between the two sections.  A film 
thickness of 1.7±0.2 μm was calculated from 5 different chips.  The film thickness of 1.0 
μm was estimated experimentally from the rate of response of the membrane coated 
sensors (Section 3.2.3).  
2.4.9 Equipment and Setup 
FlA experiments were performed with the FIA-AFAS.  Unless otherwise 
indicated, no mixing coil was used in the experiments.  The distance between the sample 
injection point and the flow-through detector cell ranged from 2 to 12.5 inches.  CV and 
CA measurements were performed using the FA-AFAS in continuously flowing or static 
solutions.  All Teflon connector tubing utilized in the AFAS had an inner diameter of 
0.03 inches and an outer diameter of 1/16 of an inch.  2-stop Tygon tubing with an inner 
diameter of 1.14 mm was used for the peristaltic pump.  The flow rates from 54 to 580 
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μL/min were used.  In the literature flow rates can range between 1 and 3600 μL/min.
3, 24, 
35, 42, 51, 64, 72, 75, 77, 84, 93, 96
  Offline beaker measurements were performed with the CHI 900 
potentiostat (CH Instruments, Austin, TX).   
2.4.10 Statistical Analysis 
 Statistical analysis was performed using One-Way and Two-Way ANOVA, t-test, 
and the Grubbs‟ test.  An alpha value of 0.05 was used for all statistical tests.  Statistical 
tables are shown in Appendix B.     
2.5 Results and Discussion 
To characterize the AFAS (i) the performance characteristics of the valves, (ii) the 
reproducibility of repeated measurements, (iii) the feasibility of the utilization of CA and 
CV techniques, and (iv) the feasibility of utilizing different flow operational schemes 
(Section 2.2), were evaluated.   
2.5.1 Characterization of the FIA-AFAS 
2.5.1.1 6-PD Valve vs. 6-PL Valve: Injector Valve Performance Characteristics 
In Section 2.1 the 6-PL and 6-PD valves were described.  In the literature, almost 
exclusively, loop valves are used in FIA experiments.  However, time-based injections 
using the 6-PD valve offers greater flexibility in designing FIA experiments.  In this 
section the characteristics of the 6-PL and 6-PD valves are compared as injector valves in 
combination with the FIA-AFAS and the Teflon block flow-through detector cell.  In 
these experiments, a sample plug volume of 54 μL was injected in the carrier stream.  
The flow rate of the carrier stream was 108 μL/min. For the 6-PL valve, the length of the 
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sample loop was 4.66 inches (ID: 0.03 inches).  For the 6-PD valve, a flow rate of 108 
μL/min and an injection time of 30 seconds were used to inject the 54 μL volume sample.  
The 54 μL time-injected volume was verified by measuring the mass of DI water pumped 
for 30 seconds at 108 μL/min.   
Figure 2-16a shows i-t transients recorded in the FIA experiments using the 6-PD 
and 6-PL valves.  The flow scheme shown in Figure 2-3 was used in combination with 
the 6-PL valve.  Figure 2-4 shows the flow scheme used in combination with the 6-PD 
valve.  The tubing between the injector valve and the detector was 7.3 inches.  10 mM 
K3Fe(CN)6 was used as the sample solution, and the CA transients were recorded at a 
potential of 0.5 V vs. Ag/AgCl.  Unless otherwise stated, this potential is used in all the 
experiments described below.  In the case of each valve, four sample injections were 
made during the period of the experiment.  The experiment was repeated 5 times for each 
valve, resulting in a total of 20 injections per valve.  
A differential peak height (DPH) is calculated for each of the injections.  The 
value of the background current that was measured 5 seconds before the injection was 
subtracted from the peak current value (i.e., current at C
max
).  Figure 2-16b displays the 
DPH for each injection. The Grubbs‟ test for statistical outliers was performed on each of 
the data sets.  One value in the 6-PD data set (circled in Figure 2-16b) was designated as 
a statistical outlier.  This value was removed from the statistical analysis.  There is 
significant overlap in the DPH values for each valve.  The 6-PD and the 6-PL have an 
average DPH of 1.58±0.07 and 1.62 x1±0.09 μA, respectively.  The relative standard 
deviation (RSD) of the DPH for the 6-PD is 4.3% (n=19).  The DPHs for the 6-PL valve 























6PD Valve 6PL Valve
8-1) allows the acceptance of the null hypothesis that there is no difference between the 
mean DPH values of the two valves.  The method of sample injection does not seem to 
significantly affect the dispersion profile of the injected plug.  Therefore, the 6-PD valve 
can be used as an injector valve, and the 6-PL offers no significant advantage in 
performance over the 6-PD valve.     
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Figure 2-16:  (a)  Current-time transients recorded in a FIA experiment upon 4 
consecutive injections of 54 μL volume of 10 mM K3Fe(CN)6. Carrier Electrolyte: Buffer 
1.  Flow Rate: 108 μL/min. Teflon flow-through detector cell.  Applied potential: 0.5V 





2.5.1.2 6-PD Valve Performance for Sample Injections between 2 and 54 μL Volumes  
To determine the volume range in which the 6-PD valve may be used as an 
injector valve, the reproducibility of FIA transients were evaluated by injecting sample 
volumes between 2 and 54 μL.  The injection protocol was the same as shown Figure 2-
16a.  The i-t transients are shown in Figure 2-17a.  Figure 2-17b displays the average 
DPHs for each time-injected volume with standard deviations (n=20).  Using the flow 


















































Figure 2-17:  (a) Current-time transients recorded in a FIA experiment upon 4 
consecutive injections of 100 μM K3(Fe(CN)6).  Injected Volumes: 2, 5, 13, 27 and 54 
μL.  6-PD valve.  Carrier Solution:  Buffer 1.  Teflon block flow-through detector cell.  





Table 2-1 displays the average DPH and the RSD (n=20) for each of the time-
injected volumes.  Single outliers in the 2 and 27 μL data sets were removed.  Data from 
54 μL time-injected volume transients are shown in Table 2-2.  The average DPH (n=4) 
and SD are calculated from the 4 injection peaks in each transient.  Using ANOVA, the 
SD values shown in the last column of Table 2-2 were compared to the SD values 
calculated from the DPHs of the other time-injection volumes (2, 5, 13, and 27 μL not 
shown).  No significant difference was found between the SD values for each of the data 
sets, F(4,20)=1.62, p=0.21.  This means that a constant „noise‟ signal (i.e., standard 
deviation) is detected in all of the measurements, but the effect of the „noise‟ isn‟t as 
noticeable for the larger time-injected volumes.  This is reflected in the SD and RSD 




Table 2-1:  Average DPH of the current-time transients recorded in the FIA experiments 
with (± 1SD) and RSD (n=20) values for time-injected volumes ranging between 2 and 
54 μL.  *Data sets displaying single outliers (n=19).  
Time-Injected Volume 
(μL) 
Average DPH (Amperes) 
n=20 
RSD 
2 (0.9±0.2) x 10
-7
* 20.6% 
5 (1.9±0.2) x 10
-7
  12.1% 
13 (2.6±0.2) x 10
-7
  5.6% 
27 (3.8±0.2) x 10
-7
* 4.9% 
54 (4.3±0.1) x 10
-7





Table 2-2:  DPH values, their means and standard deviations from the i-t transients 



















































































Inserting a mixing coil between the injector and the detector has been shown to 
improve the reproducibility of measurements.
53, 69
  A mixing coil with an inner diameter 
of 0.03 inches and a length of 12.5 inches was inserted between the 6-PD valve and the 
flow-through detector cell.  The time-based injection experiment was repeated using the 
same injected volumes and flow rate.  Because of its large RSD in the previous 











































Figure 2-18:  (a) Current-time transients recorded in a FIA experiment upon 4 
consecutive injection of 100 μM K3Fe(CN)6 using the and a 12.5 inches long mixing coil 
was placed between the injector and the detector cell.  Injected Volumes: 5, 13, 27 and 54 
μL.  Carrier Solution:  Buffer 1.  Flow Rate: 108 μL/min.  Teflon block flow-through 
detector cell. Applied potential: 0.5 V vs. Ag/AgCl.  (b) Average DPHs ± 1SD (n=20) vs. 




The i-t transients recorded with a 12.5" long mixing coil are shown in Figure 2-
18a.  With the mixing coil, the distance between the valve and the flow-through detector 
cell was increased.  This results in a greater dispersion of the sample zone.  The time it 
takes for the sample to reach the flow-through cell was also increased.  Using a flow rate 
of 108 μL/min, the analysis time for a single injection was approximately 4 minutes.  The 
transients displayed in Figure 2-18a are noticeably broader, while the peak heights are 
smaller when compared to Figure 2-17a.  Figure 2-18b displays the average DPHs (n=20) 
with respect to the time-injected volume.  There is approximately a 14% decrease in the 










Table 2-3:  Average DPH of the current-time transients recorded in the FIA experiments 
with (± 1SD) and the RSD (n=20) values for time-injected volume between 5 and 54 μL 
using mixing coil.  *Data sets displaying single outliers (n=19). 
Time-Injected Volume 
(μL) 


















Comparing the SD values seen in Tables 2-1 and 2-3, the mixing coil decreased 
the SD values, on average, by a factor of three.  Consequently, the RSD values were 
decreased, on average, by a factor two.  The improvement in the SD of the DPH values is 
statistically significant, (p=7x10
-5
).  This suggests that a mixing coil improves the 
reproducibility of the measurement across time-injected volumes.    
In summary, it was found that the 6-PD can be used as a time-based injector 
valve, and the reproducibility of the injection is similar to that of 6-PL valve.  Unlike the 
6-PL valve, the 6-PD valve can be easily configured to inject a wide range of sample 
volumes.  In general, the mixing coil improves the reproducibility of the measurement.  
The improvement was especially significant for small time-injected volumes.  However, 
the use of the mixing coil increased the analysis time, e.g., reduces the number of 
injection per minute.      
2.5.1.3 Performance of the Response Characteristics of the FIA-AFAS using 
Calibration Standards  
In FIA the concentration of an unknown sample is derived from a calibration 
curve which has been recorded in the same manifold under the same experimental 
conditions, (injected volume, flow rate, etc.) using standard solutions.  The precision and 
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accuracy of the results depend on the reproducibility of the measured quantity (e.g., DPH, 
area of the transient curve, etc.) in repeated measurements and the quality of the 
calibration curve.  The quality of the calibration curve can be characterized by the 
residual mean standard deviation (RMSD) of the individual points around the fitted line. 
To demonstrate the performance characteristics of the FIA-AFAS for 
determination of unknown samples, FIA calibration curves were recorded by injecting 
FcMeOH of different concentrations (1 to 100 μM) into the carrier stream.  In these 
experiments the 6-PD valve was used to inject a 27 μL volume sample plugs into the 


























































Figure 2-19:  (a)  Current-time transients recorded following consecutive injections in a 
FIA experiment with 27 μL injection volume. Injected Sample Concentrations: 1, 5, 10, 
50, and 100 μM FcMeOH.  Carrier Solution: Buffer 1.  Clamp-style flow-through 
detector cell.  Applied potential:  0.5 V vs. Ag/AgCl.  (b)  First 500 seconds of the 
current-time recording displaying 3 injection of the 1 μM FcMeOH sample.  (c)  




Figure 2-19a displays i-t transients recorded during the calibration measurement.  
Each analyte is injected three times.  The entire experiment was repeated twice.  Figure 
2-19b shows the i-t transient following the injections of 1 μM FcMeOH.  Figure 2-19c 
displays the average DPH±1SD (n=6) measured at different concentrations and a line 
fitted to the calibration points by linear least-squares regression.  As expected, the DPH is 
directly proportional to the sample concentration. Table 2-4 displays the average DPHs 
and their RSDs.  The somewhat larger RSD at the 1 μM concentration may be related to 
the incomplete decay of the residual current before the first measurement (Figure 2-19b). 
 
 
Table 2-4:  Average DPH of the current-time transients recorded in the FIA experiments 
with (± 1SD) and the RSD (n=6) values for a 27 μL injected volume.    


















2.5.2 Characterization of the FA-AFAS 
Compared to the FIA-AFAS, The FA-AFAS provides a variety of measurement 
possibilities.  The following experiments demonstrate the FA-AFAS ability to: (i) 
perform measurements in static and flowing solutions, (ii) perform concentration gradient 
measurements, and (iii) perform repeated measurements over a long time period.   
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2.5.2.1 Calibration Measurements Performed under Hydrodynamic Conditions  
The FA-AFAS can be used to perform measurements under flowing conditions.    
Six standard solutions from 1 to 100 μM FcMeOH were used.  The flow-through detector 
cell was filled with the standard, and an electrochemical measurement was performed in 
the flowing standard solution.  Both cyclic voltammetry (CV) and chronoamperometry 
(CA) were used as the electrochemical technique.  The i-E transients for the CV 
experiments are shown in Figure 2-20a.  The i-t transients for the CA experiments are 


















































Figure 2-20:  (a) Cyclic voltammetry and (b) chronoamperometric transients recorded in 
flowing sample solutions with the 10 μm MEA chip.  Sample Concentrations: 1, 5, 10, 
50, and100 μM FcMeOH.  CVs applied at a scan rate of 100 mV/s.  CA i-t transients 
recorded at a potential of 0.45 V vs. Ag/AgCl for 60 seconds.  Background Electrolyte: 





Figure 2-21 shows two calibration curves constructed from the limiting currents 
in Figure 2-20a and the steady-state currents in Figure 2-20b.  Using linear least-squares 
regression, Equations 6 and 7 were derived from data in Figure 2-21.   
 
 









The RMSD values for fitted lines representing the calibration cures recorded in 




A, respectively.  Detection limits 
(DL=3xRMSD/slope) are 5±2 μM and 2.0±0.7 μM for CV and CA experiments, 
respectively.  As expected, the CA technique had a somewhat better DL compared to the 
CV measurements.   








 cm, and l=1.5x10
-4
 cm, the number of individual microdisk electrodes in on 
the 10 μm MEA was calculated as N= 390±19.  The number of microdisks estimated 
from the microdisk patterned area of the MEA is 359±5.  This number was calculated 
based on the number of individual microdisk that could fit on the 3 mm diameter MEA 
surface.  There is an 8.3% percent difference between the N derived electrochemically 
and the N calculated from the physical area.   Inaccuracies in the diffusion coefficient and 






Figure 2-21:  Steady state and limiting current values plotted vs. concentration from the 
CV and CA transients recorded in solutions flowing at a rate of 54 μL/min.  The figure 




In these experiments the FA-AFAS successfully utilized two electroanalytical 
techniques in flowing solutions. Detection limits consistent with the applied 
electroanalytical techniques were achieved.    
2.5.2.2 Measurement of Sample Dispersion with the FA-AFAS in Stopped Flow 
The FA-AFAS can be used to measure a specific region of a dispersed injected 
sample if: (a) the flow of solution is stopped, and (b) the volume of the injected sample is 
greater than the flow-through detector cell volume.  An example of a dispersed sample 
plug is shown in Figure 2-22b.  At t0 (t=0) the plug is injected into the carrier solution, 
and the plug has a homogenous concentration profile in the tubular flow path (Figure 2-
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detector cell, and a background current would be measured by the detector.  Each region 
between t0 and tn, regions „1‟ to „11‟, corresponds to: (i) a concentration in the dispersed 
sample plug, and (b) a time in which that region comes in contact with the detector.  For 
example, the detector will encounter the region at time „1‟ before the region at „2‟.  If the 
flow of solution is stopped at time points „1‟ through „11‟ and voltammetric 
measurements are performed in the stopped solutions, the measured currents will 
represent the concentrations of the dispersed sample at the selected time points. For 
example, if the flow of solution is stopped at region „4‟ the measured current would be 
proportional to C
max
.  From these data, it is possible to construct the concentration profile 
of the dispersed sample of a FIA experiment.           
The FA-AFAS has been used to construct a FIA transient, following the injection 
of a 54 μL volume sample of 100 μM FcMeOH, from individual measurements 
performed in consecutive segments of the injected plug.  The dispersed sample plug was 
separated into 17 regions.  Each region corresponded to a 2 second advancement of the 
dispersed sample plug within the flow though detector cell.  At t=0 seconds the sample 
plug is injected into a carrier stream.  Four seconds (t = 4 s) after the injection, the flow 
was stopped, and a CV was applied at a scan rate of 100 mV/s.  The plug was then 
advanced 2 seconds (t = 6 s) and another measurement was performed.  This step-by-step 
procedure was repeated in 2 second intervals until t = 38 seconds after the injection.  
Figure 2-23 displays the overlaid CVs for measurements recorded in regions t=4 to t=38 
seconds.  The amplitude of the peak currents are gradually increasing (Figure 2-23a) in 
the first phase of the FIA experiment until the concentration reaches C
max
.   Figure 2-23b 
displays CVs with gradually decreasing peak current values corresponding to the second 
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phase of the experiment, when the plug is washed out of the cell, i.e., C
max
 decays to C = 
0.  At time t = 38 s the analyte plug has completely cleared the flow-through detector cell.  












Figure 2-22:  (a) Initial sample plug as it is injected into the tubular flow path.  (b)  
Dispersion profile of an injected sample plug.  The 11 time points labeled on the time 
axis correspond to 11 concentration regions of the dispersed sample.  Time interval t=4 
corresponds to C
max





























































Figure 2-23:  Overlaid CV transients recorded in 17 segments of a single 54 μL volume.  
(a) CV transients recorded in the first phase of a FIA transient, from t=4 s until the 
concentration in the cell reaches C
max
. (b) CV transients recorded in the second phase of 
the FIA transient, from t=20 s until the dispersed sample has cleared the flow-through 
detector cell. Scan Rate: 100 mV/s.  Injected sample concentration: 100 μM FcMeOH. 
Working Electrode: 2 μm MEA. Carrier Solution: Buffer 2.  Clamp-style flow-through 
detector cell.  6-PL valve.  Flow Rate: 540 μL/min. 
 
 
Figure 2-24 displays an i-t transient constructed from the peak currents of the CVs 
in Figure 2-23.  The error bars show the SD across five experiments.  The shape of the 
constructed i-t transient is representative of the concentration profile of the injected 
sample plug.       
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Figure 2-24 Flow injection transient constructed from the peak current values in Figure 2-
23.  Inserts:  Selected CVs from Figure 2-23 corresponding to time points at t=10, 14, and 




The above experiment was also completed for FcMeOH concentrations of 20 to 
80 μM.  Because the 6-PL valve was used, the sample concentrations were switched 
manually. Table 2-5 displays the peak current values at C
max
 for each concentration.  In 
total, twenty-five 54 μL plugs (5 for each concentration) from 20 to 100 μM FcMeOH 
were measured.  The RSD values in the last column of Table 2-5.  The reproducibility of 
the measurements is consistent with previous FIA results (Table 2-3).      














































































































Table 2-5 Peak currents, mean, and RSD (n=5) of the CV transients at the time region of 
C
max




















































































The average peak current values from Table 2-5 are plotted versus the sample 
FcMeOH concentration in Figure 2-25.  Using linear least-squares regression, a slope of 
2.6x10
-9
 A/μM was derived from data in Figure 2-25.  The detection limit was calculated 
as 7±2 μM (DL=3xRMSD/slope).  These results are consistent with previous 


























Figure 2-25:  Calibration curve plotting the average peak current values in Table 2-5 




2.5.3 Long-term Monitoring Experiments with the FA-AFAS   
Ferrocenemethanol was used as a model compound to demonstrate the 
performance of the AFAS in long-term continuous monitoring experiments.  In this 
protocol a 54 μL volume samples were analyzed every five minutes for 6 hours.  
The 2 μm IDA was used as the working electrode, with both sides of the IDA 
interconnected.  The interconnected electrodes have to same electrochemical properties 
as a macroelectrode.  The total distance between the injector and flow-through detector 
cell included a 12.5 inch mixing coil and 2 inches of connecting tubing.  In the course of 
the monitoring experiment, five standard solutions of 1 to 80 μM FcMeOH were used as 
samples.  Sample plugs were moved into the flow-through detector cell and stopped at 
the time interval corresponding to C
max
.  A CA measurement was then performed by 
applying 0.4 V vs. Ag/AgCl for 60 seconds.     
Figure 2-26a shows the chronoamperometric i-t transients recorded in 5 minute 
intervals in 0, 20, 40, 60, and 80 μM FcMeOH solutions.  The total procedure time was 
36 minutes.  To construct a calibration curve, background subtracted values taken at t=58 
seconds of the i-t transients were plotted against the concentration (Figure 2-26b). 
Utilizing the cycle control, described in Section 2.1, the experiment was repeated 10 
times, producing 10 calibration curves, and resulting in a total experimental time of 6 
hours.  The slopes of the calibration curves were determined by linear least-squares 
regression.  Across the 10 experimental cycles, the average slope value of the calibration 
curves was 0.040±0.002 (A cm
3
/mole).  The RSD (n=10) of the slope values was 4.2%.  
An average detection limit of 5±2 μM for the data taken at t=58 seconds was calculated 
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using 3xRMSD/slope.   The calculated detection limit was consistent with the 
electrochemical technique. 
Overall, the results discussed above show that the FA-AFAS is adequate to 




















































Figure 2-26:  (a)  Cycle 1 chronoamperometric i-t transients performed in 54 μL samples 
stopped at C
max
.  One sample is measured every five minutes.  Sample Concentrations: 0, 
20, 40, 60, and 80 μM FcMeOH.  Carrier Solution: Buffer 1.  Flow Rate: 324 μL/min.  
Clamp-style flow-through detector cell. Applied Potential: 0.4 V vs. Ag/AgCl for 60 
seconds.  (b) Current values at t=58 seconds of the transients in Figure 2-26a. vs. the 




To determine whether the analysis time can be shortened without compromising 
the reproducibility and detection limit of the measurements, calibration curves were also 
constructed and analyzed using the current values measured at t= 0.5, 1, 2, 5, 10, and 20s.  
The results are summarized in Figure 2-27.  The slope values (A cm
3
/mole) are plotted on 
the left Y-axis.  The detection limits (moles/L) are plotted on the right Y-axis.  On the X-
axis the points used for evaluation of the slopes and DLs are labeled.  As expected, the 
amplitude of the slope values change depending on the time „t‟ in which the values were 
taken from the i-t transient.  From the Cottrell equation (Equation 3), it is known that the 
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measured signal decays with the inverse square-root of time.  Ten detection limit values 
were calculated for each time category (Table 8-2).  The average of the detection limits 
(n=10) are shown in Figure 2-27 for each time category.  Using ANOVA, it was 
determined that there is no significant difference between detection limits calculated at 
the various times, F(6,63)=0.46, p=0.84 (Figure 8-2).  This can be explained by the data 
in Figure 2-27 and Table 2-6.  As the time increases, there is a decrease in the sensitivity 
(i.e., slope) and the standard deviation of the measurement.  From the data, it is clear that 
shorter measurement times could possibly be used.  However, the shorter measurement 
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Figure 2-27:  Slopes of the calibration curves and the detection limits for t= 0.5, 1, 2, 5, 
10, 20, and 58 s.  Left Y-axis:  Slope values (A cm
3
/mole).  Right Y-axis: Detection 
limits calculated from the RMSD and the slope (moles/L).  X-axis: time value of the 
measured data.  The graph show the percent deviation in the calculated slopes of the 





Table 2-6:  SD and RSD values of the slopes (S) in Figure 2-27 
Time 
(seconds) 




RSD of  S 
(n=10) 
0.5 1.2E-02 5.6% 
1.0 7.1E-03 5.2% 
2.0 5.5E-03 5.6% 
5.0 4.0E-03 5.7% 
10.0 3.9E-03 5.5% 
20.0 2.7E-03 5.1% 
58 1.7E-03 4.2% 
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2.5.4 Day-to-Day Reproducibility of Measurements using Planar MEA Electrodes 
 Propofol sedation can range from hours to days.  It was of interest to determine 
the performance of the microfabricated electrode over several days of use.  The 
experiment described in Section 2.5.3 was repeated three times over the course of one 
week.  Between experiments, the electrode remained within the flow-through detector 
cell filled with DI water.  Unless otherwise indicated, the protocol was the same as 
described in Section 2.5.3.  
The FA-AFAS was used in combination with the 6-PL.  The 6-PL valve was used 
to inject a 69 μL sample plug into a carrier stream of Buffer 2 solution. The carrier stream 
was pumped at a flow rate of 540 μL/min.  The clamp-style flow through cell was used in 
combination with the 0.5 mm silicon gasket and a 2 μm MEA chip.  Five standard 
solutions with concentrations between 1 to 80 μM FcMeOH were used.  The current 
readings at t=58 seconds of the i-t transients were used to construct calibration curves.   
Table 2-7 summarizes the results of the experiment.  Statistical outliers were 
identified by the Grubbs‟ test.  Within each day, a RSD value of less than 2% was seen 
without outliers.  When outliers are included, the RSD values were less than or equal to 
3.2%.  The improved RSD values are attributed to the increased sample plug volume.  









Table 2-7:  Average slope values (S) of calibration curves and the RSD with and without 
statistical outliers. 
 S without 
outliers (A/M) 
(n=9) 










 1.7% 2.8% 




 1.5% 2.3% 














An ANOVA of the slope values (Table 8-3) from the 3 data sets (i.e., Day 1, Day 
4, and Day 7) showed a significant difference between the data sets, F(2,24)=57.3, 
p<0.001 (Figure 8-3).  However, no significant difference was found between the Day 4 
and the Day 7 data sets, t(16)=0.45, p=0.66 (Figure 8-4).  This box-plot in Figure 2-28 is 
a graphical representation of the data shown in Table 2-7. The statistical outliers were 
excluded.  In agreement with the statistical analysis, it shows that Day 4 and Day 7 data 
sets have a similar range and median value, as opposed to the Day 1 data set.   
Despite the statistically significant difference in the slopes of the calibration 
curves recorded at Days 1, 4, and 7, there is only a 4.2% RSD between all the data sets.  
The difference in the slopes is probably caused by changes in the electrode over time.  In 
extended experiments, periodic calibration can be used to compensate for these changes.  
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2.6 Conclusion 
The purpose of the experiments summarized in Chapter 2 was to demonstrate the 
capability of the AFAS as an automated flow analytical system though selected 
examples.  Measurements were performed using various experimental conditions 
including a wide range of sample volumes, and sample concentrations.  The experiments 
utilized two flow through-detector cells and a variety of electrode configurations.  
Through examples, it has been shown that the AFAS is able to implement a FIA 
experiment using either the 6-PL or the 6-PD valve.  The AFAS is also able to perform 
stopped flow CA or CV measurements  Calibration experiments can be completed using 




























demonstrate the AFAS‟s ability to apply two electrochemical techniques, 
chronoamperometry and cyclic voltammetry, and to achieve detection limits consistent 
with these techniques. The AFAS can be used to implement a continuous monitoring 
protocol over extended time periods. 
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3 CHARACTERIZATION OF THIN POLYMERIC FILM MODIFIED 
ELECTRODES IN THE FIA-AFAS 
To determine if the AFAS can be used in combination with an organic film coated 
sensor, ferrocenemethanol was used a model compound.  The differences between a 
membrane modified and an unmodified electrode has been studied.  In these studies we 
compared the: (i) response time of the working electrode, (ii) steady-state current value 
for a given sample concentration, (iii) the analysis time (i.e., time from injection for the 
sample to completely clear the flow-through detector cell), (iv) detection limit, and (v) 
reproducibility of the of the measurements using a membrane modified electrode and a 
bare electrode.   
3.1 Theory 
The response of the membrane modified electrode is affected by the mass transport 
in the solution and in the membrane and the rate of electron transfer between the analyte 
and the electrode.  When the membrane coated electrode is placed into the aqueous 
solution, FcMeOH partitions between the aqueous sample and the membrane.  As shown 
in Figure 3-1a, at equilibrium the concentrations are constant and independent of the 
distance from the electrode.  C
0
 is the sample concentration. CS is the concentration at the 
film/aqueous interface.  CM is the membrane concentration.  δ is the thickness of the film.  
CE is the electrode surface concentration.  x is the distance from the surface of the 
electrode.  The membrane concentration can be calculated from the partition coefficient 








































































where κ is the partition coefficient.  At equilibrium the membrane surface concentration 
(CS) and the sample concentration (C
0
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Figure 3-1:  Schematic of the concentration profiles of a membrane coated electrode at 
(a) equilibrium and at (b) steady-state after application of an adequate potential.   The 
distances are not shown to scale. Reproduced and modified from Marrese et al., Bard et 
al., and Leddy et al.
2, 50, 59
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After application of an adequate potential, the electrode surface concentration of 
FcMeOH drops to zero.  At steady state, the flux in the membrane is equal with the flux 
through the aqueous solution layer.  The concentration profiles at steady state in the 
membrane and the adjoining aqueous layer are shown in Figure 3-1b.  At steady-state the 

















where JFilm is the flux in the film.  DM is the diffusion coefficient within the film.  The 















where JAqueous is the flux in the aqueous solution.  Φ is the thickness of the diffusion layer 
outside of the film.  DS is the diffusion coefficient of the FcMeOH in aqueous solution.  
The thickness of the diffusion layer under laminar flow is in the micrometer range.
52
  
This is the same order of magnitude as the thickness of the membrane.  The diffusion 




/s.  While the diffusion 




/s.  This value is 
based on diffusion coefficient measurements in ISE membranes.
48, 71
  Consequently, for 
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Equations 9 and 10 to be equal, the concentration polarization in the aqueous solution 
layer must be much smaller than in the membrane.  In agreement with this statement, the 




3.2 Results and Discussion 
3.2.1 Flow Injection Analysis with a Polymeric Membrane Coated Electrode 
The influence of a thin polymeric membrane, coated on the surface of the working 
electrode, has been evaluated.  In these studies, the 6-PD valve was used in combination 
with the FIA-AFAS to make timed-injected volumes ranging from 27 to 360 μL.  
FcMeOH concentrations from 5 to 80 μM were used as the injected samples.  The carrier 
solutions was flowed for 30 seconds before samples injections were made.  The flow-
through detector cell was located 5.8 inches from the injector.  These measurements were 
completed with both an unmodified and a 1.0 μm thick membrane modified 2 μm MEA 
chip.   
Figures 3-2a and 3-2c display the overlaid i-t transients following the injection of 
different volumes of 5 μM FcMeOH concentration.  The dispersion of the sample plug is 
described by Equation 4 (Section 2.1).  As the injected volume increases there is an 
increase in the peak height of the transients.  If the injected sample volume is larger than 
180  μL, C
max
 becomes equal to C
0
 and the i-t transients reach a steady-state.  This is 
shown in Figures 3-2b and 3-2d, where the DPHs of the i-t transients are plotted versus 
the time-injected volume.  Figures 3-2a and 3-2c appear very similar, but the amplitude 

















































































5μM 20μM 40μM 60μM 80μM
 
Figure 3-2:  Overlaid FIA i-t transients of 27, 45, 64, 90, 180, 360 μL injection volumes 
of 5 μM FcMeOH with (a) an unmodified and (c) a 1.0 μm thick membrane modified 2 
μm MEA electrode.  Carrier Solution: Buffer 2.  Flow Rate: 540 μL/min.  Clamp-style 
flow through detector cell.  6-PD valve.  Applied Potential: 0.5 V.  DPHs from the i-t 
transients for different time-injected volumes of 5, 20, 40, 60 and 80 μM FcMeOH 
solutions for the (b) unmodified and (d) 1.0 μm thick membrane modified 2 μm MEA 




The RSD of the DPH values for the unmodified and the 1.0 μm thick membrane 
modified electrode are summarized in Tables 3-1 and 3-2, respectively.   
Two-way ANOVA was used to test if the SDs of the DPHs for the unmodified 
electrode (Table 8-4) were influenced by either the concentration or the volume of the 
injected sample. A F(4,16)=1.3, p=0.31 (Figure 8-5) allows the acceptance of the null 
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hypothesis that there is no significant difference in the SD of the DPHs with respect to 
injected volume.  A F(4, 16)=1.8, p=0.16 (Figure 8-5) allows acceptance of the null 
hypothesis that there is no significant difference in the SD of the DPHs with respect to 
concentration.  This translates into larger RSDs following the injection of dilute samples 
and small injected volumes.   
 A two-way ANOVA was also performed on the 1.0 μm thick membrane 
modified electrode FIA results (Table 8-5).  A F(5,20)=1.0, p=0.5 (Figure 8-6) allows the 
acceptance of the null hypothesis that there is no significant difference in the SD values 
based on injected volume.  A F(4, 20)=1.5, p=0.23 (Figure 8-6) allows acceptance of the 
null hypothesis that there is no significant difference in the SD values based on 
concentration.   
 
   
 
Table 3-1:  The RSD (n=5) of the DPHs recorded with an unmodified electrode in FIA 
experiments.  Injections were made with of different sample volumes and concentrations.  
‡No data.   
Injected Volume (μL) 5 μM 20 μM 40 μM 60 μM 80 μM 
27 4.9% 1.1% 2.3% 0.8% 0.1% 
45 0.6% 1.1% 1.5% 0.4% 0.1% 
64 1.9% ‡ 0.7% 0.8% 0.6% 
90 0.5% 0.6% 0.6% 0.5% 0.8% 
180 0.8% 0.1% 0.4% 0.2% 0.4% 













Table 3-2:  The RSD (n=5) of the DPHs recorded with an 1.0 μm thick membrane 
modified electrode in FIA experiments.  Injections were made with of different sample 
volumes and concentrations. 
Injected Volume (μL) 5 μM 20 μM 40 μM 60 μM 80 μM 
27 12.6% 1.9% 2.7% 3.4% 0.3% 
45 11.2% 0.5% 1.6% 0.2% 0.0% 
64 2.0% 0.3% 1.4% 0.6% 0.5% 
90 1.0% 1.0% 0.0% 1.0% 0.4% 
180 0.6% 0.0% 0.3% 0.2% 0.4% 




In Figure 3-3 the DPH of the i-t transients are plotted as a function of the 
concentration.  The figure is a alternative representation of the data shown in Figure 3-2b.  
It demonstrates the linear response of a voltammetric sensor.  The larger time-injected 
volumes provide a higher sensitivity than the smaller volumes.  This same trend was 








Figure 3-3:  DPHs plotted versus the concentration of the injected sample for injected 




Figure 3-4 shows the average DPH versus the injected volume for a 1.7 μm thick 
membrane modified electrode.  The DPH of the signals were approximately 1.7 times 













































5μM 20μM 40μM 60μM 80μM
 
Figure 3-4 : DPH values of the i-t transients recorded following injections of 5, 20, 50, 
60, and 80 μM FcMeOH solutions. Injected Volumes: 27, 45, 64, 90, 180, 360 μL.  
Electrode: 1.7 μm membrane modified electrode. Carrier Solution:  Buffer 2.  Flow Rate:  




It was of interest to determine if the thickness of the membrane had any affect on 
the analysis time.  Figure 3-5 displays three i-t transients following the injection of a 27 
μL volume of 80 μM FcMeOH.  The three curves were recorded with an unmodified, a 
1.0 μm thick membrane modified electrode, and a 1.7 μm thick membrane modified 
electrode.   The current recorded with the unmodified electrode decays back to its 
background value after approximately 35 seconds, following the injection.  For the 
membrane modified electrodes, the analysis time was only slightly longer, approximately 



















of the sample plug through the flow-through detector cell and the additional 10 seconds 
was needed for the removal of FcMeOH from the film.   
The peak heights of the FIA transients are affected by the thickness of the 
deposited membrane.  The unmodified electrode has the largest peak, while the 1.7 μm 
thick membrane modified electrode has the smallest.  The measured current is directly 
proportional to the flux of FcMeOH to the electrode surface (Equation 9).  The flux is 
inversely proportional to the film thickness.  Electrodes modified with a thicker film are 





Figure 3-5:  Current-time transients recorded in FIA experiments following injection of 
27 μL of 80 μM FcMeOH with an unmodified MEA electrode, a with MEAs coated with 
1.0 and 1.7 μm thick membranes. 
 
 
   
The influence of the membrane thickness on the sensitivity of the measurements 
is also seen in Figure 3-6.  The figure shows FIA calibration curves recorded with 
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unmodified and membrane modified MEAs.  The sensitivity is the highest with the 
unmodified electrode.  Linear least-squares regression was used to derive the slope values 
of the calibration curves.  
 
 
Figure 3-6:  Calibration curves constructed from the DPHs following the injections of 
360 μL volume samples with different concentrations.  The steady-state i-t transient 
values (i.e., 360 μL injected sample volume) of a 2 μm MEA working electrode, without 




The detection limits of the regression lines were calculated using 
DL=3xBackground Current/Slope.  The results are shown in Table 3-3.  At a time-
injected volumes larger than 64 μL, the 1.0 μm modified electrode offers detection limits 
similar to DLs reported for unmodified electrodes with common voltammetric techniques 
(i.e., CA or CV).   
Each of the above experiments required approximately 6 ½ hours to complete.  If, 
































1.7μm 1.0 μm Umodified
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measured every 5 minutes for 6 ½ hours, for the 64 μL injected sample volumes, only a 5 
mL of sample would be used.  The utilization of ~5 mL of sample for a 6 ½ hours 




Table 3-3:  Detection limit of for the unmodified and modified electrodes across all 
injected volumes.  Detection limits calculated using DL=3xBackground Current/Slope 
Volume Injected (μL) 
Unmodified 
[μM] 
1.0 μm Film 
[μM] 
27 4 ± 1 11 ± 4 
45 3 ± 1 9 ±  3 
64 2.4 ± 0.8 7  ± 2 
90 2.3 ± 0.8 6 ± 2 
180 2.1 ± 0.7 6 ± 2 




3.2.2 Determination of the Diffusion Coefficient of FcMeOH within the Polymeric 
Membrane and the Determination of the Membrane Thickness 
The time dependent change in concentration on the electrode surface of a 









                                                                                     (11) 
 
 
where Cs(t) is the time dependent concentration on the sensing surface.  C0 is the 
concentration outside of the membrane before it is changed (t<0).  C∞ is the concentration 
outside the membrane after it is changed according to a step function (t≥0).  τ is the time 
constant.    
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In voltammetric analysis the current is directly proportional to the concentration; 










































i(t) is the time dependent current.  i0 is the current before the concentration change.  i∞ is 
current after the step change in concentration.  

  is the thickness of the membrane.  DM is 
the diffusion coefficient in the film.  t is time in seconds.  If the thickness of the 
membrane coating is known, the diffusion coefficient of the analyte in the film can be 
calculated by fitting Equation 12 to the i-t transients following a step change in 
concentration.  Figure 3-7 shows the i-t transients recorded with 1.0 and 1.7 μm thick 
membrane modified electrodes after injection of 360 μL of 80 μM FcMeOH.  The dashed 
lines are the fitted curves.  Using exponential least-squares regression, Equations 14 and 
15 were calculated as best-fit functions for the 1.0 and 1.7 μm thick membrane modified 
electrodes, respectively.  The time constant (τ) value for the 1.7 μm thick membrane 
modified electrode is 9.22 (Equation 15).  Using Equation 13, τ=9.22, and a known film 
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Figure 3-7:  Current-time transients following an injection of  360 μL volume of 80 μM 
FcMeOH for the 1.0 and 1.7 μm membrane modified electrodes. Dashed-lines fitted to 

































m                                                                       (15) 
 
    
 



































 The time constant values derived in Equations 14 and 15, and the known 
membrane thickness of 1.7 μm were used to calculate the thickness of the 1.0 μm thick 
membrane.  Because the diffusion coefficient for FcMeOH is the same for all membrane 
thicknesses, Equation 13 can be rearranged to solve for an unknown film thickness.  











                                                                                            (16) 
 
3.3 Conclusion 
These experiments showed that the AFAS can be used for automated voltammetric 
analysis with membrane coated electrochemical cells, using ferrocenemethanol.  The 
sensitivity of the measurement is affected by the thickness of the membrane deposited on 
the surface of the electrode.  Thinner membranes have higher signal amplitudes and 
better detection limits.  By using thinner membranes, relatively small sample volumes 



































4 MEASURMENT OF 2,6-DIISOPROPYLPHENOL USING THE AFAS IN 
COMBINATION WITH THIN POLYMER FILM MODIFIED ELECTRODES 
AND THE AFAS 
The membrane covered, planar, microfabricated chip has been used to measure 
propofol (2,6-diisopropylphenol).   Propofol is highly lipophilic and has an octanol/water 
coefficient of 6761:1.
19
  Since propofol is so lipophilic, it preferentially partitions into the 
membrane from the aqueous solution.  Figure 4-1 shows a schematic membrane coated 
electrode at equilibrium.  The concentration of propofol within the membrane (CM) is 
expected to be much higher than in the aqueous sample solution (C
0





Figure 4-1:  Schematic of the propofol concentration profiles in a membrane coated 








The electrochemical oxidation of propofol is a complex process.  Depending on the 
experimental conditions, the products of the electrochemical oxidation may deposit onto 
the working electrode surface, inducing serious electrode fouling.  Electrode fouling is 
common during the electrochemical oxidation of phenolic compounds.
40, 68, 90
  Electrode 
fouling at solid electrodes may prevent their analytical use.  The renewal of the electrode 
surface by polishing or by electrochemical treatments may change the sensing surface 
area.
92
  It was observed that electrode fouling, caused by propofol oxidation, could be 
minimized by performing the cyclic voltammetry measurements in a limited potential 
window
47
 or in an organic solvent.
44
 
Similar to the experiments discussed in Chapter 3, a membrane modified gold 
electrode was used for the measurement of propofol.  Only limited information is 
available on the direct electrochemical detection of propofol with a gold electrode.  
Thiagarajan et al. and Langmier et al. have reported propofol measurements performed 
with preanodized carbon and glassy carbon electrodes, respectively.
47, 79
  In this work, 
microfabricated, planar gold macroelectrodes were modified with the PVC membrane.  
These modified electrodes were used for propofol measurements.  These experiments are 
designed to: (i) determine the feasibility of automated voltammetric analysis of propofol 
with the membrane coated electrodes; (ii) determine the precision and accuracy of 
propofol measurement in the physiologically relevant concentration range; (iii) determine 
the affect of electrochemically active compounds commonly present in human serum and 
blood samples on propofol measurements; and (v) compare the performance of propofol 
measurements with membrane coated sensor to that of ferrocenemethanol.  
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4.1 Membrane Conditioning/Cleaning   
The background currents with the membrane coated sensor were unexpectedly 
large at potentials near the propofol oxidation potential.  This large current was related to 
impurities in the membrane.  To reduce this current a conditioning/cleaning step was 
necessary before the propofol measurements could be performed.  The film modified 
electrode was placed in a Buffer 2 solution, and the potential of the working electrode 
was scanned between 1.2 and 1.8 V at a scan rate of 100 mV/s.  The conditioning was 
applied until the amplitude of the current decreased to a value of approximately 2x10
-7 
A 
or remained constant across 10 consecutive scans.  Figure 4-2b shows the conditioning 
for a membrane coated gold macroelectrode in 1480 CVs.  The current at 1.8 V decreased 
from 2.4x10
-6
 A to approximately 4.8x10
-7 
A.  For FcMeOH measurements with the 
membrane coated electrode, conditioning was not required because FcMeOH has been 
oxidized at much lower potentials where the impurities in the membrane did not 
contribute to the background current.  Figure 4-2a shows 10 CVs recorded between 0 and 
0.5 V at a scan rate of 100  mV/s.  In this potential window, the background current was 
















































Figure 4-2:  Membrane Cleaning using CV in Buffer 2 solution recorded with membrane 
coated gold electrode.  (a)  CVs recorded between 0 to 0.5 V with a scan rate of 100 




4.2 Results and Discussions 
Before the flow analytical measurements of propofol with the AFAS, batch 
experiments were performed.  These experiments were performed to establish that: (i) 
propofol measurements can be performed with a membrane covered electrode without 
fouling of the sensing surface; and (ii) measurements can be performed within the 
physiological concentration range of propofol.   
For these measurements, the planar electrochemical cell was coated with a 1.0 μm 
thick polymer film and exposed to an aqueous propofol solution.  The large 
macroelectrode located on the 2 μm MEA chip was used as the working electrode.  A 
platinum coil electrode was used as an external counter.  A Ag/AgCl electrode was used 
as an external reference.  Buffer 2 was used as the background electrolyte.  Figure 4-3 
shows five CVs performed in 9.99 μM of propofol over a period of 20 minutes.  A 
potential window of 1.0 to 1.6 V and a scan rate of 100 mV/s was used.  A beaker filled 
with 10mL of Buffer 2 was spiked with 10 μL of 10
-2 




















t=0 min t=5 min t=10 min t=15 min t=20 min
initial CV, performed directly after the propofol addition (t=0 min), no faradic signal 
related to propofol oxidation was detected.  After five minutes another CV was 
performed, and an oxidation peak for propofol was detected at a potential of 1.45 V vs. 
Ag/AgCl.  CVs were performed every five minutes in the same solution until the 
propofol signal reached a steady-state.  The CVs performed at 15 and 20 minutes have 
the same peak current.  It is assumed that the concentration of propofol in the membrane 
is gradually increasing until it reaches a equilibrium with the aqueous solution.  Based on 





Figure 4-3: Cyclic voltammetry transients performed in 9.99 μM propofol + Buffer 2 
solution performed over a period of 20 minutes.  The potential of the working electrode 
was scanned from 1 to 1.6 V at a scan rate of 100 mV/s.  The working electrode is a gold 
macroelectrode modified by a 1.0 μm thick membrane film.  An external platinum coil 




Monitoring of propofol during anesthesia requires a measurement frequency 
which is less than 5 minutes per measurement.  Consequently, measurements should be 
performed before the sensor reaches steady state.  If sequential measurements can be 
performed using reproducible time intervals, measurements can be made without having 
to wait for steady-state.  FIA is ideally suited for these types of measurements.  
CV measurements were performed in three minutes intervals in increasing 
concentrations of propofol solution using 2 μm MEA microfabricated chip with a 1.0 μm 
thick membrane coating.   On the 2 μm MEA chip, the 0.0125 cm
2
 gold marcroelectrode 
was used as the working electrode.  The other 0.158 cm
2
 on-chip macroelectrode was 
used as the reference and counter electrode.   
A beaker of 10mL of Buffer 2 was spiked with 1 to 10 μL of aliquots of the 
propofol stock solution.  After each addition, the electrode was allowed to equilibrate in a 
stirred solution for three minutes before a CV measurement was performed.  The 
potential of the working electrode was scanned from 1.0 to 1.9 V at a scan rate of 100 
mV/s.   
Figure 4-4a displays the CV transients performed in a concentration range of 1 to 
90 μM propofol.  As the concentration of propofol is increased, there is a corresponding 
increase in the signal amplitude.  In the measurements shown in Figure 4-4a, the peak 
potential of the transients shift towards a more positive potential as the concentration of 
propofol was increased.  In measurements where an external reference electrode was used 
in combination with a membrane coated working electrode, a stable peak potential was 
maintained.  To construct a calibration curve current values measured at 1.7 V were used.  
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Figure 4-4b shows the calibration curve.  A detection limit (DL=3xRMSD/Slope) of 6.2 
μM was calculated.  
This experiment demonstrates the feasibility of the quantitative measurement of 
propofol with precision timing, e.g., measurements can be performed before steady-state 
conditions are established.  The AFAS is well suited to perform measurements where 














































Figure 4-4:  (a) Cyclic voltammetry transients performed in propofol concentrations from 
1 to 90 μM propofol.  The 2 μm MEA chip was modified by a 1.0 μm thick membrane 
film.  The small gold on-chip macroelectrode was used as the working electrode.  The 
large on-chip macroelectrode was used as the counter and reference electrode. 
Concentration changes were made by standard additions 1 and 10 μL of 10
-2
 M propofol 
stock solution into 10mL of Buffer 2 solution.  After each standard addition, the system 
was allowed to equilibrate for 3 minutes before a CV was performed.  The potential of 
the working electrode was scanned from 1 to 1.8 V at a scan rate of 100 mV/s.  (b) 




.   
4.2.1 Flow Injection Analysis with a Polymeric Membrane Coated Electrode 
Although the therapeutic range of propofol is between 1 and 90 μM, the typical 
blood concentrations are between 1 and 50 μM. The response of a 1.0 μm organic film 




 gold marcorelectrode was used as the working electrode.  The other 0.158cm
2
 
on-chip macroelectrode was used as the reference and counter electrode.  The distance 
between the injection site and the flow-through detector cell was 5.8 inches.  The FIA-
AFAS in combination with the 6-PD valve was used to inject 540 μL propofol solutions 
with concentrations ranging between 1.99 and 49.8 μM.  The i-t transient is shown in 
Figure 4-5.  The first injection was performed 1200 seconds following the application of 
the voltage.  During these 1200 seconds the charging current decays to a background 
































Figure 4-5:  FIA i-t transient following the injections of 540 μL of 1.99, 9.99, 24.7, 39.8, 
and 49.8 μM propofol solutions.  The current was allowed to decay to a stable 
background current for 1200 seconds before the first injection was made.  Carrier 
Solution: Buffer 2.  Washing Time Between Injections: 3 minutes.  Clamp-style flow 





 The experiment shown in Figure 4-5 was repeated 5 times using the cycle control 
for a total experiment time of 3 ½ hours.  Figure 4-5 shows the DPHs across 5 cycles for 
each concentration.  Figure 4-6a shows the DPHs for 1.99 and 9.99 μM propofol 
concentrations.  Figure 4-6b shows the DPHs for 24.7 to 49.8 μM propofol 
concentrations.  The Grubbs‟ test was performed on the data to test for statistical outliers.  
None of the DPH values could be considered as an outlier.   













































Figure 4-6:  Cycle-to-cyle DPHs from the FIA i-t transients are shown (a) 1.99 and 9.99 
μM propofol concentrations, and (b) 24.7, 39.8, and 49.7 μM propofol concentrations 
across 5 experimental cycles.   
 
 
Table 4-1 displays the RSD values for the individual propofol concentrations 
across the five cycles. 
 
 
Table 4-1:  RSD of the DPHs shown in Figure 4-6. 










 Figure 4-7a shows the calibration curve for Cycle 1.  The DPHs taken from 
Figure 4-6 are plotted versus the injected sample concentration.  The slope values for all 
5 cycles are plotted in Figure 4-7b.  There is a 10.9% RSD (n=5) in the slope values.  The 
calculated detection limits (DL=3xRMSD/Slope) range between 7.5 (Cycle 5) and 13.3 
μM (Cycle 2).      
 
 




















































Figure 4-7:  (a) Calibration curve generated from DPHs of the FIA i-t transients  in Cycle 
1.  (b) Cycle-to-cycle changes in the slopes of the calibration curves across the five 
experimental cycles.      
    
 
 
 Attempts were made to generate calibration curves for smaller injected volumes 
of propofol (i.e., 27 to 360 μL), similar to the FcMeOH volumes seen in Chapter 3.  
However, these attempts were unsuccessful.  The background current at 1.8 V is 
approximately 50 times larger than the background current at 0.5 V, which was used 
during the FIA experiments with FcMeOH in Chapter 3.  To increase the sensitivity of 
propofol measurements and to improve the DL, the propofol injected sample volume had 
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to be increased.  An injected volume of 540 μL was the minimum volume necessary to 
perform an FIA experiment with propofol.  
In Figure 4-8 the calibration curves for propofol (Figure 4-7a) and FcMeOH 
(Figure 3-6) are compared.  Although a direct comparison of the propofol data to the 
FcMeOH data may not be justified, qualitative statements can be inferred.  The larger 
sensitivity of the propofol measurement is a result of its larger partition coefficient 
compared to FcMeOH.  The ratio of the two slopes does not reflect the partition 
coefficients.  This is due to the differences in the experimental conditions while recording 
the two calibration curves.  The FcMeOH DPH values represent the injected sample 
concentrations without dispersion (i.e., steady-state values), while the propofol DPH 
values represent sample concentrations which were not in steady state with the membrane 
film.  This lends support to the claim that propofol preferentially partitions into the 
membrane, and provides a higher electrochemical signal compared to hydrophilic 
compounds with same aqueous sample concentration.   
 
 

































Figure 4-8:  Comparison of the propofol calibration curve from Figure 4-7a and FcMeOH 
calibration curve from Figure 3-8. 
 
 
4.2.2 Flow Injection Analysis of Propofol in the Presence of Hydrophilic Interferences 
Propofol measurements were performed in the presence of common hydrophilic 
interfering compounds of 4-acetamido-phenol (i.e., acetaminophen, Tylenol) and L-
ascorbic acid.  The oxidation potential for ascorbic acid (AA) was reported as 0.27 to 
0.35 V vs. Ag/AgCl.
95
  The oxidation potential of acetaminophen (AC) was reported as 
0.5 V vs. Ag/AgCl.
41
  The maximum blood concentration for adults who received a 
1000mg dose of Adult Tylenol Liquid is approximately 126 μM.
83
  Serum concentrations 
of AA have been reported as 54 to 64 μM.
66
    
Interference concentrations of 7 times the propofol concentration were used to test 
the interferences on the propofol signal.  The interference concentrations were also 
greater than the reported maximum serum concentrations.  Analyte solutions of: (1) 158.4 
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μM AA, (2) 142.9 μM AC, (3) 20 μM propofol, (4) 20 μM propofol + 158.4 μM AA and 
(5) 20 μM propofol +142.9 μM AC were all formulated in Buffer 2.  The 20 μM propofol 
solution was chosen because it is a median concentration in the physiological 
concentration range of propofol.  To decrease the dispersion factor and to increase signal 
amplitude, the length of tubing between the valve and the flow-through detector cell was 
decreased to 2 inches.  Unless otherwise stated, all other experimental conditions (i.e., 
valve, flow-through detector cell, etc.) were as described in 4.2.1.     
Five sequential injections of the analyte solutions were made.  Between sample 
injections, a wash time of 10 minutes was used.  The transient is shown in Figure 4.9.   
The cycle control was used to automatically repeat the experiment 5 times, for a total 
experiment time of 5 hours and 25 minutes.   
It is apparent from Figure 4-9 that the presence of AA and AC causes some 
interference in the propofol measurement.  The response for propofol plus AC or AA is 
greater than the response for propofol alone.  Although the response for AA and AC 
alone is not large compared when compared to the 20 μM propofol response, the presence 
of AA or AC may be problematic when attempting to measure extremely low 




























Figure 4-9:  FIA i-t transient following the injection of 540 μL volumes of (1) 158.4 μM 
AA, (2) 142.9 μM AC, (3) 20 μM propofol, (4) 20 μM propofol + 158.4 μM AA and (5) 
20 μM propofol +142.9 μM AC solutions. The current was allowed to decay to a stable 
background current for 600 seconds before the first injection was made. Carrier Solution: 
Buffer 2.  Wash Time: 10 minutes.  Flow Rate: 540 μL/min. Applied Potential: 1.8 V.  




Figure 4-10 shows the changes in the background current and the peak currents 
(i.e., absolute current value at C
max
) for the various propofol formulations (i.e., with and 
without AA/AC) across all five experimental cycles.  As shown in Figure 4-10a, the 
background signal gradually increases over time.  It is assumed that this increase is 
related to the accumulation of propofol in the membrane, although a relatively long 
washing time of 10 minutes was used.  Because of propofol‟s highly lipophilic nature, it 
may be impossible to completely remove all the propofol from the membrane by washing 
with buffer alone.  The data in Figure 4-10a suggests, that the membrane is slowly being 
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saturated with propofol and a steady-state background value is being reached in the 
membrane.   
Figure 4-10b shows a gradual decrease in the peak currents across the five 
experimental cycles. The gradual increase of propofol concentration in the membrane 
may play some role in the gradual decrease in the current response.  The decrease in the 
peak heights indicates that the induced concentration change in the membrane over time 
is decreasing.   
Although there is a decrease in the measured peak heights over time, the RSDs 
are not large.  For the 20 μM propofol solution, the RSD of the peak currents is 2.6% in 
the five experimental cycles.  The peak currents for propofol + AC and propofol + AA 
formulations had RSD values of 6.0% and 5.7%, respectively. 
 
 








































Figure 4-10:  Cycle-to-cycle changes in background current and peak height across five 
experimental cycles.  (a) Background current values from the FIA i-t transients for the 
various propofol formulations across five experimental cycles.  (b) Peak current values 







Although the feasibility of propofol measurements with the AFAS has been shown, 
there is room for improvement.  To produce a measurable signal, propofol FIA 
measurements required significantly larger sample volumes compared to those used with 
FcMeOH FIA measurements.   Reduction of the necessary sample volume may be 
possible by performing measurements in stopped flow mode, and allowing the membrane 
to saturate for a period of time before a measurement is performed.   
Overall, these measurements show that: (i) the AFAS can be used to perform 
propofol measurements with a membrane modified electrode; (ii) propofol can be 
measured with the membrane modified electrode without detrimental fouling; (iii) 
changes in the measured electrochemical signal are directly proportional to changes in the 
propofol sample concentration; and (iv) propofol preferentially partitions into the 
membrane giving increased measurement sensitivity compared to hydrophilic 
compounds.   
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5  AFAS LIMITATIONS 
5.1 Control Program/System 
The control programs of the AFAS have been specifically designed to interface 
with the instruments detailed in Section 1.2.1.  Specific drivers were written to 
control the Gilson peristaltic pump and the Hamilton MVP. 
5.1.1 Electrochemical Characterization 
Before the AFAS can be used for monitoring the concentration of a compound, the 
electrochemical properties of the compound have to be investigated.  The same 
working and reference electrode used in these investigational measurements must also 
be used with the AFAS.   
1. In CV measurements the optimal potential for the CA experiments performed with 
the AFAS must be determined. 
2. In CV and/or CA experiments the magnitude of the measured current, in the 
concentration range of interest, must be determined.  The expected current value is 
required for determining the appropriate gain setting on the BAS CV-27 potentiostat. 
5.1.2 Flow System Characterization 
Before the AFAS can be used for monitoring the appropriate following parameters 
have to be determined in preliminary experiments: 
1. How long it takes a sample plug of a given volume to travel from the point of 
injection to the flow-through detector cell. 
 103 
2. .How long it takes a sample of a given volume to completely clear the flow-through 
detector cell and for the measured signal to return to a background value.  This will 
determine the maximum sampling frequency. 
3. The minimal sample volume necessary to achieve the required precision and accuracy 
during monitoring. 
4. The optimal flow rate. 
5. The optimal distance between the injector and the detector, with or without a mixing 
coil.   
6. Whether the electrochemical measurements will be performed in flowing solutions or 
under stopped flow. 
Before the AFAS is used for monitoring, the user should ensure that the properties of 
the solutions are in compliance with the specifications of the MVP valve.       
5.2 Propofol Measurements with the AFAS 
No measurements were made in serum, plasma, or whole blood.  Consequently, 
limitations related to measurements in theses samples are not known at this time.  The 
usage life and shelf life of the propofol sensor are unknown at this time.  No 
measurements were made with propofol injectable emulsion solution.  It is unknown how 
the highly lipophilic compounds present in the injectable emulsion solution will affect the 







6 CONCLUSIONS AND FUTURE WORK 
The goal of this work was to: (1) develop and automated flow analytical system; (2) 
demonstrate its performance characteristics in a variety of sampling and fluidic schemes; 
(3) show its performance characteristics in combination with a film modified 
electrochemical sensor; and (4) show the feasibility of propofol monitoring with the 
AFAS.   
The completed experiments emphasize the capability of the AFAS as an 
automated flow analytical system.  The AFAS is able to accurately meter analyte 
volumes down to 5 μL, and perform electrochemical measurements in both flowing and 
stopped flow solutions.  Precision timing allows experiments to be repeated the same way 
every time.  The AFAS can be used in continuous monitoring situations, and has been 
used to perform periodic measurements every 5 minutes for 6 ¾ hours.  Accurate 
measurements can be made both in stopped-flow and flowing solutions.  Flow injection 
analysis can be performed, and the AFAS has the ability to isolate and perform 
electrochemical measurements on specific regions of an injected sample plug.   
The feasibly of long term voltammetric measurements with membrane coated 
electrodes were also shown.  Measurements made with ferrocenemethanol had an average 
RSD of 1.7% for the 1.0 μm thick membrane modified electrode.  Detection limits of 5±2 
μM were calculated for the 1.0 μm thick membrane modified electrode    
Long-term voltammetric measurements made with propofol also showed promise.  
Measurements were made using propofol concentrations within the physiological range.  
Experiments showed that hydrophilic interferences hardly influence the signal of the 
membrane coated propofol sensor.  
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Future propofol experiments will focus on using a glassy carbon electrode 
because of its larger sensitivity, compared to the gold electrode, to phenolic compounds.  
Also, experimental protocols will be developed to perform measurements in stopped-flow 
mode to reduce the necessary sample volume.  Future experiments will also compare the 
performance characteristics of the propofol sensor in the presence and absence of 
different levels of albumin in the sample solutions.   Lastly, the electrochemical activity 
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7 APPENDIX A:  AFAS MANUAL 
The automated flow analytical systems (AFAS) is composed of a flow-through 
electrochemical cell, a computer controlled actuator (Modular Valve 
Positioner (367898), Hamilton Company, Reno, NV), multi-position valve (6-port 
Distribution Valve/6-port Loop Valve (36781/ 38760), Hamilton Company, Reno, NV), 
peristaltic pump (Miniplus3 Peristaltic Pump (F1155006), Gilson Incorporated, 
Middleton, WI), and potentiostat (CV-27 Cyclic Voltammagraph (MF9030), in 
combination with a PA-1 Pre- Amplifier (MF2200), Bioanalytical Systems Incorporated, 
West Lafayette, IN). The AFAS has a user-friendly graphical interface, which allows for 
easy configuration of the system. The user interface was designed using LabVIEW 
(National Instruments Corporation, Austin, TX).   
7.1 AFAS Components Overview 
Figure 7-1 shows a schematic view of the instrument communication/control and 
the fluid pathways.  The computer contains the control program that communicates with 
each instrument in the system.  Each of the instruments are connected to the computer 
through various interfaces.  The potentiostat is connected to the computer via the NI-6221 
DAQ card and USB port.  The Modular Valve Positioner (MVP) is connected directly to 
the computer via the COM1 serial port.  The peristaltic pump is connected to the 
computer via the 506C interface and the COM2 serial port.  Analytes/reagents are 
selected by the MVP.  The peristaltic pump is used to flow the selected analyte/reagent.  
The selected analyte/reagent passes through the flow-through electrochemical cell which 
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houses the electrode/sensor and is deposited in a waste container.   Brief descriptions of 
each instrument are detailed below.  For a full description of the instrument operation 





Figure 7-1:  AFAS communication and fluid flow 
 
 
7.2 Bioanalytical Systems (BAS) Potentiostat and Amplifier 
The control program interfaces with the BAS model CV-27/PA-1 potentiostat via 
the NI-USB-6221 Multifunction DAQ.  Figures 7-2 and 7-3 display the front and rear 
panel of the CV-27.  To perform electrochemical measurements the waveform of the 
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card, which applies the equivalent voltage waveform to the Voltage Input Terminal (VIT) 
located on the rear panel of the BAS potentiostat.  The BAS potentiostat then applies the 
input voltage to the working electrode and the current response received by DAQ is saved 
by computer.  The Cell Mode, located on the front panel, should be set to CELL during 
an experiment and be turned to STBY (i.e., standby) after the experiment.  When set to 
CELL the electrode/sensor is connected to the CV-27 electronics.  When set to STBY the 



















The Initial E knob (V), located on the front panel,  is a dual function knob that 
controls initial potential that is applied when the cell is connected and a voltage 
waveform is not being applied to the VIT.  The control program should be used to set this 
potential.  The knob should only be used to make small adjustments so that the actual 
potential applied matches the accumulation potential set by the AFAS.   
The Gain knob (mA/V) is located on the front panel.  The gain serves a dual 
function as a current to voltage conversion and an amplification factor.  The gain should 
be set according to expected current range from the electrode/sensor. 
The rear panel of the BAS potentiostat is used primarily to connect to external 
devices for input, recording, and power.  The rear controls of note are described below.  
The Cell port allows the connection between the electrochemical cell and the electronics.  
The red, white and black wires of the cell connector cable should be connected to the 
auxiliary/counter, reference, and working electrodes; respectively.  I Out (V) outputs the 
voltage based on the current-to-voltage converter/gain control on the front panel.  The 
voltage is directly proportionally to the current being generated by the electrochemical 
reaction.  The conversion factor is the gain setting on the front panel.  The App. E output 
is the potential applied to the working electrode of the electrochemical cell.     
7.3  BAS PA-1 Amplifier 
If using a microelectrode it is recommended that the BAS PA-1 Amplifier be used.  



















The Cell Mode is a toggle switch located on the front panel.  To connect the PA-1 
electronics to the electrochemical cell, the control switch should be set to ON.  Otherwise 
it should be set to OFF.   
The Gain knob is used to set the amplification and the current-to-voltage 
conversion factor. The Multiplier knob sets a number in which the gain is multiplied by.  
When the PA-1 is used in combination with the CV-27 the total gain (A/V) is calculated 
















The PA-1 is connected to the electrochemical cell through a control box located 
on the faraday cage. 
 
 
    
 






The Low Current Input port, located on the rear of the PA-1port is connected to 
the faraday cage through a connector cable (Figure 7-6).   When using the PA-1 in 
combination with the CV-27 the Cell port, located in the rear of the CV-27, should be 
connected to the Cell port located on the faraday cage.  On the inside of the faraday cage 
are cables to connect to the electrochemical cell.  The color codes are the same as 
described above for the CV-27 cable. 
7.4  NI-6211 Data Acquisition (DAQ) Instrument  
The NI-6211 DAQ hardware digitizes signals, performs digital to analog 
conversions to generate analog output signals, and measures analog input signals 
63
.  The 
NI-6211 is connected to the computer via an USB port.  This connection allows the 
control program to interface with the BAS model CV-27/PA-1 potentiostat via the NI-
USB-6221. To perform electrochemical measurements, the waveform of the desired 
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electrochemical technique is sent from the control program to the DAQ interface card 
which applies the equivalent voltage waveform to the voltage input terminal (i.e., the Ext. 
In. jack) at the rear of the BAS potentiostat.   The BAS potentiostat then applies the input 
voltage to the working electrode.  The NI-6211 receives input from the I Out and App. E 
output jacks.  The I Out jack sends the response current to the applied potential to the 
control program via the NI-6211.  The App. E sends the actual applied potential to the NI-
6211.  This potential along with the I Out current is used by the control program to 
construct the cyclic voltammetry response curve.  The chronoamperometric response 
curve is constructed using current from the I Out jack and the time from the applied 
chronoamperometric waveform.  
7.5 Hamilton Modular Valve Positioner 
The Hamilton Modular Valve Positioner (MVP) automatically changes the position 
of the installed valve according to an electronic command sent through the COM1 
port.  The MVP has a rotation speed of 20 RPM.  It is able to perform a complete 
revolution in three seconds, in either the clockwise or counterclockwise direction.  The 
control program has the ability to determine the shortest path to the required valve 














The front and rear panels of the Hamilton MVP are shown in Figure 7-7.  The 
valves should be locked into the valve connector port located on the front panel.  The 
valve indexing pin should be lowered.  The MVP Input port should be connected to the 
COM1 port of the computer.   
7.5.1 Valves 
At this time our lab has two Hamilton MVP valves in stock.  A schematic of the 












Each MVP valve has an internal cylinder that can be rotated in the clockwise or 
counterclockwise direction.  The rotation of the cylinder in the 6-Port Distribution (6-PD) 
valve allows for the selection of analyte/reagent solutions from 6 inlet ports.(Figure 7-8a)  
The 6-PD valve has a dead volume of 27.2 μL. 
The 6-Port Loop (6-PL) valve is rotated to change the orientation to two flow 
configurations, Load and Inject.  In the Load position the attached sample loop is 
bypassed.  In Inject position the sampled loop is connected, and the sample washed to the 
detector.  The 6-PV valve has a dead volume of 7.5 μL. 
Presently, the Hamilton MVP is electronically calibrated to use a 6 port valve.  For 




















7.6 Gilson Peristaltic Pump and 506C Interface 
The Gilson peristaltic pump is used to pump the solution selected by the Hamilton 
MVP into the flow-through cell.  It is controlled via the Gilson 506C System Interface. 
The control program is used to set the flow rate of solution, and start/stop the pump.  
The 506C Interface is connected to the computer via the COM2 serial port and the 
RS232 located at the rear of the 506C Interface.  A RS485 level cable is then connected 
from the GSIOC port, at the rear of the 506C Interface, to the GSIOC port located at the 
rear of the Miniplus3.   
7.7 Flow Analytical and Flow Injection Analysis Programs 
There are two control programs for the AFAS.  The graphical interfaces of the 
programs are similar in design and functionality, each having many of the same drop-
menus, pop-up windows, controls and indicators.    
7.7.1 Graphical Interface Description 
The graphical interface for each control program is displayed in Figures 7-9 and 
7-10.  The interface is made of up of controls (parameters that require user input) and 
indicators (parameters that display information about the experiment).  The graphical 
interface of the FA program is divided into five sections, and the FIA program is divided 
into seven sections. 
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7.7.1.1 Section 1 - Experimental Procedure 
Experimental Protocol Control – The experimental protocol control is a key 
component in the control program.  This control allows the user to input an experimental 
protocol using one line/row for each step in the experimental procedure.  Each step in the 
experimental procedure is composed of a cluster of five elements (1) Valve Position (2) 
RPM, (3) Pump Time, (4) Wait Time and (5) Measure Control.   These elements are 
explained in detail below.   
a) Valve Position – This control allows the user to select a specific valve position for 
a specific protocol step.  This control is a menu selection type control.  The user 
should click on the downward arrow by the valve control box to select the valve 
position from a menu. 
b) RPM – The RPM (rotations per minute) control allows the user to select the 
rotation speed of the peristaltic pump for a specific protocol step.  This control is 
a numerical control.  The user should enter a decimal numerical value.  
c) Pump Time – The pump time control specifies how long the pump will be active 
for a specific protocol step.  This control is a numerical control.  The user should 
enter an integer numerical value.   
d) Wait Time – The wait time control specifies a wait time for a specific protocol 
step.  If measure control is active then the pump will be deactivated during the 
wait time and a measurement will be done in stopped-flow mode (no solution 
flowing).  If a wait time is not specified and the measure control is active the 
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measurement will be done in hydrodynamic mode (solution flowing).  This 
control is a numerical control.  The user should enter an integer numerical value. 
e) Measure – The measure control specifies if a measurement will be taken during a 
specific step of the experimental protocol.  This is a Boolean control.  It is either 
ON or OFF.  A green, oval LED is used for this control.  When the LED is bright-
green measurement if ON at that step.  When the LED is opaque-green 
measurement is OFF for that step.  
Section 1 is the same in both the FA and FIA programs, except the FIA program does not 
contain a Measure control. 
7.7.1.2 Section 2 - Drop-Down Menus and Pop-Up Windows 
Section 2 contains the drop-menus.  The menus were designed to increase the 
functionality of the control programs and to optimize use of the available display space.   
The Experimental Procedure menu (Figure 7-11) contains options that affect the 
Experimental Procedure.  The options are as follows: 
1. New (Short-cut Key: Ctrl+N): Loads a new/empty experimental procedure 
2. Open (Short-cut Key: Ctrl+O): Loads a previously saved experimental procedure 











 The Valve menu (Figure 7-12) allows the user to select the valve that is currently 
in use in the system. The menu options are as follows:  
1. 6 Position (Ctrl+P) – Allows the user to select the six position distribution valve. 
2. 6 Loop (Ctrl+L)  -  Allows the user to select the six position loop valve. 
Selection of either valve option opens a pop-up window and allows the user to specify the 
solutions attached to each position. Figure 7-13 displays the pop-up configuration 
windows for each of the valves.  The user can also use the default position names by 




















The Electrochemical Parameters menu (Figure 7-14) allows the user to select 
from two electroanalytical techniques. This menu option is not available in the FIA 
program.  Selection of either menu option opens a pop-up window which allows the user 
to enter the technique parameters. The waveform approximation of the parameters is 
displayed on the front panel.  Figure 7-15 displays the pop-up configuration window for 
each of the electrochemical techniques and the Waveform Display.  The Waveform 
Display is a graphical representation of the technique parameters.  The pop-up menu 




1. Cyclic Voltammetry (Crtl+Y) - A triangular potential waveform is written to the DAQ 
card. The applied waveform is configured by entering the waveform parameters in the 
Cyclic Voltammetry Parameters pop-up window (Figure 7-15a).  
a. Accumulation Potential (volts) – The accumulation potential is the potential set 
before the cyclic voltammetry waveform is applied.  The accumulation potential 
allows the electrode to equilibrate before the CV triangular function is applied. 
b. Accumulation Time (seconds) – The amount of time in which to apply the 
accumulation potential.   
c. Initial Potential (volts) – After the accumulation time the potential is set to this 
initial potential.  This is initial potential for the cyclic voltammetry waveform.   
d. Potential Limit 1 (volts) – Potential limit 1 is the first voltage in which the 
waveform will be scanned to.  
e. Potential Limit 2 (volts) – Potential limit 2 is the second voltage in which the 
waveform will be scanned to.   
f. Scan Rate (volts/second) – The scan rate specifies the number of volts to apply 
per second.  The scan rate determines the total time to apply the cyclic 
voltammetry waveform.  
g. Number of Scans – The number of scans determines how many scans there will be 
in the applied CV waveform.   
2. Chronoamperometry (Ctrl+H) - A pulse potential waveform is written to the DAQ 
card.  The applied waveform is configured by entering the waveform parameters in the 
Chronoamperometry Parameters pop-up window (Figure 7-15b).  
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a. Accumulation Potential (volts) – The accumulation potential is the potential 
set before the chronoamperometric waveform is applied. 
b. Accumulation Time (second) – The amount of time in which to apply the 
accumulation potential. 
c. Potential 1 (volts) – After the accumulation time the potential is set to this 
initial potential.  This is initial potential for the chronoamperometric 
waveform. 
d. Potential 2 (volts) – After Potential 1, this is the voltage in which the 
chronoamperometric waveform is stepped to. 
e. Time 1 (second) – Time 1 is the length of time in which Potential 1 is applied. 
f. Time 2 (seconds) – Time 2 is the length of time in which Potential 2 is 
applied. 









The chronoamperometric technique parameters are located in Section 4 of the FIA 
program.  In this section the user is able to select from two options, Experiment and Tube 
Filling.  If the Experiment option is selected the user is able to enter the parameters for 
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the chronoamperometric pulse.  The Time 1 and Time 2 parameters are automatically 
adjusted to apply a pulse for the length of the experimental procedure.  If the Tube Filling 
option is selected the chronoamperometric technique parameters are grayed out and 





Figure 7-15:  Pop-up configuration window for (left) cyclic voltammetry and (right) 
chronoamperometry and the Waveform Display. 
 
 
7.7.1.3 Section 3 - File Saving, Applied Waveform, Cycles 
The following controls are located in section three of FA program.   Unless otherwise 
noted, these controls are also located in Section 3 of the FIA program. 
 
 135 
1. Cycles – The cycle control determines how many times the experimental protocol 
will be run. This control allows the AFAS is to automatically perform repeated 
experiments.  
2. Path to Write – This is the folder path in which the protocol and any data will be 
saved.  This path must be manually created before the experiment is started. 
3. File Name – This is the file name under which the experimental protocol and any 
experimental data will be saved. The data will be saved as a TXT and TDMS file 
type, and the experimental procedure will be saved as a DAT file type. 
4. Gain (A/V) – This is the amplification and voltage to current conversion factor set 
on the CV-27 and PA-1 instruments.  (Note: This feature is located in Section 5 of 
the FIA program)  
5. Replicate – This control copies the experimental procedure steps already loaded.  
A new experimental procedure, with the original experimental procedure 
replicated the inputted number are times, is automatically loaded. (Note this 
feature is only available in the FIA program)  
6. Description – This control is a text box where the user can type in a short 
description of the experiment.  The description is included in the TDMS data file. 
7. Applied Waveform - The applied waveform is a graphical representation of the 
electrochemical technique parameters.  
8. User – This control is a text box where the user enters his/her name.  This 
information is included in the TDMS data file.   
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7.7.1.4 Section 4 and 6– Experimental Indicators 
The following indicators are located in Section 4 of the FA program.  These 
indicators are located in Section 6 of the FIA program. 
1. Present Cycle – This indicator displays in which cycle the protocol is currently 
running. 
2. Present Step - This indicator displays the step in the experimental procedure that 
is currently running. 
3. Pump Time Left (HH:MM:SS) – This indicator displays the amount of pump time 
left in the current protocol step. 
4. Wait Time Left (HH:MM:SS) – This indicator displays the amount of wait time 
left in the current protocol step. 
5. Total Time (seconds) – The indicator displays the time it takes to run the 
measurement. 
6. Accumulation Time (seconds) – This indicator displays the current progress of the 
accumulation time for the measurement for the current protocol step. 
7. Elapsed Time (seconds) – This indicator displays the amount of time that has 
elapsed since the beginning of the measurement. 
8. Number of Data – This indicator displays the number of data points that will be 
taken during measurement. 
9. Total Time P/W (seconds) – This feature is only available in the FIA program.  




10. Indexed File Name  – This indicator displays the File name with a numerical 
indicator of the Experimental Procedure step (in the case of FA program) and 
cycle number appended to it. 
7.7.1.5 Section 5 and 7 - Measured Signal and Sample Rate 
Section 5 of the FA program and Section 7 of the FIA display the Measured 
Signal.  The Measured Signal is a graphical representation of the electrode/sensor 
response to the applied waveform.  Section 5 of the FIA program displays the Gain (A/V) 
and Sample Rate control.  The Sample Rate control indicates time interval in seconds 
between collected samples. 
7.7.2 How the Programs Work 
The selected program is activated by pressing LabVIEW‟s Run button.  This 
button is a white arrow located in the toolbar below the File menu toolbar.  It is 
highlighted with a red box in Figure 7-16.  Once the program is activated, LabVIEW‟s 
File menu toolbar will be replaced by the program specific toolbar (i.e., Experimental 
Procedure, Valve, and Electrochemical Parameters).  The user must enter all pertinent 
information into the program (Experimental Procedure, File path, File name, Gain, etc.).  
The experimental procedure is started by selecting Experimental Procedure→ Start 
from the program toolbar.  The program interprets each step in the experimental 













Figure 7-16 displays a three-step experimental procedure entered in the FA 
program (Left) and the FIA program (Right).  In the FA program the user controls when a 
measurement will take place.   In the case of the FA program, the experiment proceeds as 
follows: 
1. Load the 1st step in the experimental procedure 
a. Send electronic command to the MVP and rotate the valve to Position 1. 
b. Send electronic commands to the peristaltic pump to (1) set pump tumbler 
rotation speed to 5 RPM and (2) activate rotation. 
c. The system then counts down the pump time from 30 seconds to zero 
d. Wait time is 0, do nothing. 
e. Measure is not active, do nothing. 
2. Load the 2nd step in the experimental procedure.   
a. Send electronic command to the MVP and rotate the valve to Position 2. 
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b. Send electronic commands to the peristaltic pump to (1) set pump tumbler 
rotation speed to 5 RPM, and (2) activate rotation. 
c. The system then counts down the Pump Time from 60 seconds to zero 
d. Send an electronic command to stop pump.  The system counts down the 
wait time from 3 to zero.  
e. The Measure Boolean is active.  The system applies the selected 
electrochemical technique and reads the response from the 
electrode/sensor.   
3. Load the 3rd step in the experimental procedure.   
a. Send electronic command to the MVP and rotate the valve to Position 1. 
b. Send electronic commands to the peristaltic pump to (1) set pump tumbler 
rotation speed to 1 RPM, and (2) activate rotation. 
c. The system then counts down the Pump Time from 200 seconds to zero 
d. Send an electronic command to stop pump.  The system counts down the 
wait time from 3 to zero.  
e. The Measure Boolean is active.  The system applies the selected 
electrochemical technique and reads the response from the 
electrode/sensor.   
Essentially the same experimental procedure is loaded in the FIA program (Figure 
7-16 Right), except there is no step-by-step measurement control.  The measurement is 
performed over the entirety of the experimental procedure.  There is also a difference in 
how the data is outputted.  With the FA program, two data files will be generated, 
because two measurement steps were performed.  With the FIA program, one data file 
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will be generated because one measurement was performed over the entirety of the 
experimental procedure. 
7.7.3 Outputted Data Files 
Three data file types (DAT, TXT, and TDMS) are automatically saved at the end 
of the experiment.  The DAT file contains the experimental procedure.  The TXT file 
contains the electrochemical response data is ASCII format.  This file can be opened in a 
numerical spreadsheet program (e.g., Excel, Origin, etc.) for analysis.  The TDMS file 
can be opened in DIAdem, a data management and processing software from National 
Instruments.  The TDMS contain the electrochemical response data and the searchable 
parameter listed below. The parameters may be searched independently or in 
combination. 
 User  
 Experiment Date/Time 
 File Name 
 Accumulation Potential and Time 
 Initial Potential 
 Potential 1  
 Potential 2 
 Scan Rate, 
 Number of Scans 
 Number of Steps 
 Electrode/Sensor Identification, 
 Electrochemical Technique 
 Potential 1 Time 
 Potential 2 Time 
 
In the TDMS file the parameters are grouped under the specific channels: Sensor 
Information, Experiment Information, Electrochemical Results, and Electrochemical 
Parameters.  Figure 7-17 shows an expanded view of an experimental data file loaded in 











Visual Basic scripts, used for automated data analysis, are written in DIAdem. 
The scripts perform the following data manipulation: FFT, Low Pass Filter, Steady State 
Value, Peak Value, Area Under Curve (Charge).  
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Table 8-1:  DPH (Amperes)  values for 6-PD and 6-PL valves.  *Statistical outlier by 





































t Critical one-tail 1.687094
P(T<=t) two-tail 0.776984
t Critical two-tail 2.02619  




Table 8-2:  Detection Limit (moles/L) calculated from 10 cycles of experiment at t=0.5, 
1, 2, 5, 19, 20, and 58 s.  Detection Limits calculated using 3x‟s RMSD divided by slopes 















6.8E-06 6.0E-06 8.1E-06 7.8E-06 9.2E-06 1.0E-05 8.1E-06 
4.4E-06 4.1E-06 5.9E-06 6.7E-06 6.0E-06 5.7E-06 5.0E-06 
2.9E-06 5.3E-06 5.5E-06 7.9E-06 5.2E-06 8.3E-06 5.7E-06 
7.8E-06 5.3E-06 4.7E-06 5.5E-06 3.8E-06 3.5E-06 3.1E-06 
8.1E-06 8.2E-06 8.0E-06 8.0E-06 6.9E-06 5.7E-06 5.6E-06 
4.7E-06 4.1E-06 6.1E-06 5.6E-06 4.0E-06 6.3E-06 5.3E-06 
3.0E-06 4.2E-06 4.0E-06 3.4E-06 4.2E-06 4.3E-06 2.5E-06 
7.4E-06 8.1E-06 6.1E-06 7.3E-06 5.7E-06 5.3E-06 5.6E-06 
7.4E-06 7.3E-06 5.6E-06 5.4E-06 7.8E-06 7.1E-06 6.4E-06 









Groups Count Sum Average Variance
.5 Seconds 10 5.53E-05 5.53E-06 4.6E-12
1 Second 10 5.69E-05 5.69E-06 2.75E-12
2 Seconds 10 6.05E-05 6.05E-06 1.62E-12
5 Seconds 10 6.25E-05 6.25E-06 2.24E-12
10 Seconds 10 5.88E-05 5.88E-06 2.98E-12
20 Seconds 10 6.11E-05 6.11E-06 3.77E-12
58 Seconds 10 5.21E-05 5.21E-06 2.45E-12
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 7.97E-12 6 1.33E-12 0.45549 0.83842 2.246409
Within Groups 1.84E-10 63 2.92E-12
Total 1.92E-10 69  




Table 8-3:  Slope values (Amperes Liter/mole) calculated from linear least-squares 
regression of calibration curves across 10 experimental cycles.  *Statistical outliers 
verified by Grubbs‟ Test. (Data discussed in Section 2.5.4) 
 






Slope 1 4.6E-04 5.2E-04* 5.0E-04 
Slope 2 4.6E-04 5.0E-04 5.0E-04 
Slope 3 4.5E-04 4.9E-04 4.8E-04 
Slope 4 4.5E-04 4.9E-04 5.0E-04 
Slope 5 4.7E-04 5.0E-04 4.9E-04 
Slope 6 4.5E-04 4.9E-04 4.5E-04* 
Slope 7 4.5E-04 4.9E-04 4.8E-04 
Slope 8 4.5E-04 4.9E-04 4.9E-04 
Slope 9 4.7E-04 4.8E-04 4.9E-04 








Groups Count Sum Average Variance
Day 1 9 0.00410995 0.000457 6.19E-11
Day 4 9 0.004434154 0.000493 5.58E-11
Day 7 9 0.004418437 0.000491 7.66E-11
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 7.42665E-09 2 3.71E-09 57.3291 7.23E-10 3.402832
Within Groups 1.55453E-09 24 6.48E-11
Total 8.98118E-09 26  
Figure 8-3:  ANOVA of data in Table 8-3.  Statistical outliers removed.  (Data discussed 




t-Test: Two-Sample Assuming Equal Variances









t Critical one-tail 1.745884
P(T<=t) two-tail 0.655
t Critical two-tail 2.119905  
Figure 8-4:  t-test of Day 4 and Day 7 data in Table 8-3.  Statistical outliers removed. 











Table 8-4:  SD values (Amperes) of five DPH measurements (n=5) for each injected 
volume and concentration for the unmodified electrode.  The 64 μL injected volume was 
removed because of missing data. (Data discussed in Section 3.2.1) 
 5 μM 20 μM 40 μM 60 μM 80 μM 
27 μL 7.1E-10 6.2E-10 2.4E-09 1.3E-09 1.5E-10 
45 μL 8.2E-11 6.8E-10 1.8E-09 8.2E-10 3.5E-10 
90 μL 8.8E-11 4.4E-10 8.3E-10 1.1E-09 2.4E-09 
180 μL 1.7E-10 5.4E-11 5.8E-10 5.2E-10 1.4E-09 




Anova: Two-Factor Without Replication 
SUMMARY Count Sum Average Variance 
27μL 5 5.2E-09 1.0E-09 7.5E-19 
45μL 5 3.7E-09 7.4E-10 4.2E-19 
90μL 5 4.8E-09 9.6E-10 7.5E-19 
180μL 5 2.8E-09 5.5E-10 2.9E-19 
360μL 5 1.3E-09 2.6E-10 4.5E-20 
5μM 5 1.1E-09 2.2E-10 7.6E-20 
20μM 5 2.2E-09 4.3E-10 6.1E-20 
40μM 5 5.7E-09 1.1E-09 8.4E-19 
60μM 5 3.9E-09 7.8E-10 2.2E-19 
80μM 5 4.9E-09 9.7E-10 8.4E-19 
ANOVA       
Source of Variation SS df MS F P-value F crit 
Rows 2.0E-18 4 5.0E-19 1.30 0.311 3.0069 
Columns 2.9E-18 4 7.2E-19 1.89 0.1622 3.0069 
Error 6.1E-18 16 3.8E-19    
       
Total 1.1E-17 24         
 
Figure 8-5:  Two-Factor ANOVA of SD values in Table 8-4 for each injected volume and 












Table 8-5:  SD values (Amperes) of five DPH measurements (n=5) for each injected 
volume and concentration for the 1.0 μm thick membrane modified electrode.  (Data 
discussed in Section 3.2.1) 
 5 μM  20 μM  40 μM  60 μM 80 μM 
27 μL 4.7E-10 4.8E-10 1.3E-09 2.9E-09 4.4E-10 
45 μL 6.5E-10 1.8E-10 1.0E-09 1.9E-10 2.5E-11 
64 μL 1.7E-10 1.5E-10 1.1E-09 7.7E-10 1.0E-09 
90 μL 1.1E-10 5.4E-10 3.5E-11 1.3E-09 8.7E-10 
180 μL 8.7E-11 2.6E-11 2.8E-10 2.5E-10 9.9E-10 




Anova: Two-Factor Without Replication 
SUMMARY Count Sum Average Variance 
27μL 5 5.5E-09 1.1E-09 1.1E-18 
45μL 5 2.1E-09 4.2E-10 1.8E-19 
64μL 5 3.2E-09 6.3E-10 2.0E-19 
90μL 5 2.9E-09 5.8E-10 2.9E-19 
180μL 5 1.6E-09 3.3E-10 1.5E-19 
360μL 5 3.8E-09 7.6E-10 7.5E-19 
5μM 6 1.9E-09 3.2E-10 5.4E-20 
20μM 6 1.6E-09 2.6E-10 4.0E-20 
40μM 6 4.5E-09 7.5E-10 2.4E-19 
60μM 6 5.5E-09 9.2E-10 1.1E-18 
80μM 6 5.6E-09 9.3E-10 5.6E-19 
ANOVA       
Source of Variation SS df MS F P-value F crit 
Rows 1.9E-18 5 3.9E-19 0.96 0.4675 2.7109 
Columns 2.5E-18 4 6.2E-19 1.53 0.2304 2.8661 
Error 8.1E-18 20 4.1E-19    
       
Total 1.3E-17 29         
 
Figure 8-6:  Two-Factor ANOVA of SD values in Table 8-5 for each injected volume and 
concentration for the 1.0 μm thick membrane modified electrode.  (Data discussed in 
Section 3.2.1) 
 
 
 
 
